TSS:Rfhg 209458.1

Basic information about the TSS

---

TSS ID: rfhg_209458.1 TSS ID(Version3): hg_179978.1 hg_179976.1 hg_179977.1 Species: human Chr: chr19		Start: 18281427 End: 18281476 Strand: -
Source datasets	FANTOM5|PRJNA615891|PRJNA4843412|DRA013844
Protocol	CAGE|SLIC_CAGE|NETCAGE
TSS cluster detected*	4

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3047997,EH38E1944143)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC169272:-8 GeneID: 3727 HGNC/MGI_ID: HGNC:6206 UniProt_ID: B6ID79 Nearer transcript ids and distances: LF372674:67 MA608251:67 X51346:73 ENST00000252818.5:-146 NM_001286968.2:-146 NM_005354.6:-146 LF384383:-146 MA619960:-146 AK223630:-146 X56681:-182 BC169273:188 LF372675:289 MA608252:289 DQ594578:360 LF208134:-424 MA443711:-424 LF213747:-424 MA449324:-424 BC169274:479 LF372676:494 MA608253:494 ENST00000600972.1:498 view more...

Gene_name: JunD proto-oncogene, AP-1 transcription factor subunit Gene_symbol: JUND Gene_synonyms: AP-1 Gene_source: HGNC:6206

TATA-Box annotation

---

Distance to TSS:	171
Nearest PromoterID:	NM_001286968
Entrez ID:	3727
Nearest Unigene:	Hs.2780
Nearest Refseq:	NM_005354
Nearest Ensembl:	ENSG00000130522
Gene Name:	JunD proto-oncogene, AP-1 transcription factor subunit
Gene Alias:	AP-1
Gene Type:	protein-coding
CpG%:	0.142857
GC%:	0.740000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@JUND p2@JUND p3@JUND p4@JUND p5@JUND p6@JUND p7@JUND p8@JUND p9@JUND p10@JUND
Sample		p1@JUND	p2@JUND	p3@JUND	p4@JUND	p5@JUND	p6@JUND	p7@JUND	p8@JUND	p9@JUND	p10@JUND
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	133.25	2.34	1.17	0.39	0.39	1.17	1.56	1.56	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	129.69	1.82	2.43	1.01	0.40	1.21	1.01	0.40	0.40	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	119.41	2.51	2.70	0.96	0.77	0.96	1.16	0.58	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	137.01	1.46	1.46	0.83	0.62	1.25	1.25	0.83	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	144.43	1.57	2.47	0.67	0.22	2.02	1.12	0.67	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	129.27	3.10	1.94	0.78	0.58	1.36	1.36	0.39	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	143.80	1.96	1.31	0.65	0.87	1.53	0.87	0.65	0.44	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	101.97	1.94	1.70	0.24	0.73	1.45	0.48	0.24	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	114.55	2.14	2.78	0.43	1.07	0.21	0.43	1.28	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	194.75	2.32	0.00	0.00	0.58	1.16	3.48	1.16	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	179.48	1.62	1.62	0.00	1.62	1.21	0.81	0.81	1.21	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	177.66	1.63	1.63	0.00	0.81	0.81	1.22	0.41	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	279.35	11.61	8.38	4.03	1.13	1.13	0.97	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	205.83	7.07	5.26	3.31	0.75	1.35	1.80	0.75	0.45	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	213.84	8.34	7.90	2.85	1.10	1.10	0.66	0.66	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	227.60	11.07	7.04	3.77	2.01	0.75	1.51	1.51	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	201.81	8.95	5.24	1.75	0.22	2.18	1.31	1.09	0.87	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	220.19	9.70	5.48	3.37	2.53	0.84	2.53	1.27	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	210.06	11.20	4.80	4.80	0.53	1.07	2.67	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	348.27	10.68	7.52	5.27	1.81	2.26	2.11	1.20	0.45	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	336.13	13.77	6.68	5.48	1.87	2.00	2.14	1.74	0.27	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	338.00	12.95	7.77	4.66	1.55	2.07	1.90	2.07	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	278.42	9.57	7.50	4.52	1.16	2.07	1.16	1.42	0.13	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	308.92	13.59	8.25	5.58	0.97	2.67	2.91	0.73	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	326.10	15.74	8.51	5.16	1.55	1.55	1.55	0.52	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	347.85	9.81	7.28	3.17	2.22	2.22	0.95	1.58	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	255.50	13.74	6.59	6.59	1.65	2.20	2.75	1.65	1.65	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	405.73	11.32	7.31	5.42	2.12	1.89	1.41	1.41	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	326.12	11.95	6.46	4.04	0.97	1.29	2.10	1.29	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	325.74	13.39	5.61	5.25	1.63	1.81	1.81	1.27	0.54	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	255.61	10.68	6.28	4.81	1.47	0.84	2.93	1.88	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	271.19	13.87	4.88	3.32	1.56	2.93	0.59	2.34	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	268.85	12.03	4.64	4.64	1.90	2.53	1.06	1.90	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	183.25	6.10	2.64	1.81	1.48	1.65	1.98	1.48	0.16	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	287.59	8.60	4.11	2.99	2.06	3.37	2.06	0.93	0.93	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	314.65	11.69	4.02	6.13	1.72	1.34	1.15	0.96	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	239.53	2.86	1.23	1.64	1.02	1.23	1.23	0.20	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	200.88	4.23	3.02	1.61	1.41	1.41	1.41	0.20	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	194.47	4.86	1.89	2.97	0.81	0.27	1.08	1.08	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	143.80	3.12	2.40	1.44	0.96	0.48	0.00	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	158.09	3.76	1.88	0.71	0.71	0.71	1.41	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	119.60	1.61	2.78	0.88	1.17	0.59	0.73	0.73	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	112.41	2.74	2.74	1.05	0.42	0.63	1.05	0.63	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	130.25	2.27	2.62	0.35	0.35	0.00	0.70	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	111.63	3.41	3.01	0.80	0.60	0.80	1.00	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	105.16	4.19	3.49	0.93	0.23	0.70	0.70	0.23	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	105.56	5.04	4.56	1.44	0.72	0.72	0.72	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	111.47	2.68	4.77	1.79	0.30	0.89	0.60	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	110.11	5.03	7.66	2.87	0.48	0.72	1.20	0.48	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	102.92	4.65	4.85	2.02	1.01	0.81	0.61	0.61	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	105.14	5.74	6.76	3.28	0.41	0.61	0.61	0.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	114.30	8.23	8.45	4.23	0.22	0.44	0.22	0.89	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	68.49	8.52	5.32	1.77	1.06	0.00	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	68.27	6.30	5.30	1.33	0.00	0.66	0.00	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	28.52	2.52	3.36	0.00	0.00	0.84	0.00	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	74.86	1.38	5.97	0.46	0.00	0.92	0.92	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	82.00	7.45	9.40	3.24	0.65	0.65	1.62	0.97	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	88.64	7.07	10.28	4.18	0.32	1.61	0.64	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	83.30	2.51	9.12	1.57	0.00	0.94	0.94	0.00	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	74.03	9.17	11.99	3.53	0.00	2.12	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	95.33	8.41	10.09	1.68	0.56	0.56	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	89.17	7.17	19.90	5.57	0.00	0.80	2.39	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	119.94	4.76	6.80	2.04	0.34	0.34	2.04	1.02	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	104.62	11.05	19.50	5.85	0.65	0.65	1.95	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	125.31	16.68	11.71	2.84	0.71	1.42	1.42	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	7.90	0.00	0.00	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	130.17	9.26	7.80	3.90	0.00	0.49	1.95	0.98	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	140.33	11.90	4.96	4.46	0.99	0.00	1.98	1.49	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	144.49	8.44	8.44	1.41	0.00	0.00	0.94	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	180.17	12.25	6.62	4.97	0.33	2.32	1.66	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	174.78	16.40	6.19	6.50	0.31	1.86	1.24	0.62	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	165.41	19.57	7.95	4.28	1.22	0.61	1.53	0.92	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	63.04	2.22	3.17	1.74	0.48	0.79	0.16	0.00	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	34.17	1.93	4.01	0.96	0.16	0.32	0.16	0.32	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	87.41	2.16	2.54	2.42	1.53	0.51	1.15	1.27	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	40.36	2.24	2.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	62.96	1.34	3.68	1.34	0.00	0.00	0.00	0.67	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	61.89	1.28	2.55	1.91	0.64	1.91	0.64	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	49.48	3.30	2.20	0.00	1.10	0.00	0.00	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	42.90	4.06	4.97	2.71	0.45	0.00	0.00	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	57.87	2.09	3.30	1.22	0.35	0.35	0.17	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	85.86	4.30	6.06	1.76	0.20	0.59	0.20	0.59	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	55.59	2.06	4.38	1.29	0.26	0.26	0.51	0.77	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	65.23	8.08	7.81	3.35	0.56	0.28	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	65.83	5.88	11.76	2.35	0.00	0.00	0.59	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	58.47	1.85	3.94	1.77	0.72	0.16	0.64	0.16	0.08	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	43.57	3.87	5.81	1.61	0.32	0.32	0.65	0.32	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	84.24	1.60	5.33	3.20	0.00	0.53	1.07	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	40.06	3.34	2.78	0.00	0.00	1.11	0.56	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	51.15	1.66	2.50	1.25	0.42	0.00	0.00	0.42	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	49.23	3.27	4.77	0.50	0.50	0.25	0.50	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	46.80	1.96	4.58	0.98	0.65	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	34.10	2.74	1.83	0.61	0.00	0.00	0.61	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	83.98	3.76	1.10	1.10	0.00	0.44	0.44	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	234.87	3.23	6.10	1.43	0.00	0.72	1.79	1.79	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	65.89	4.79	5.99	1.20	0.00	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	113.34	3.24	2.16	1.80	0.18	0.90	1.62	0.54	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	93.72	5.02	3.35	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	143.20	9.45	5.14	2.26	0.62	0.21	0.41	1.23	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	156.08	5.95	7.55	2.52	0.34	0.57	0.46	0.46	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	122.45	3.92	3.67	1.96	0.00	0.24	0.24	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	32.80	2.70	1.80	0.45	0.00	0.00	0.90	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	39.51	3.47	4.78	0.87	0.00	0.43	0.00	0.87	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	2.14	4.28	0.00	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	31.69	2.09	2.09	0.60	0.00	0.60	0.60	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	39.20	1.26	1.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	25.08	5.28	2.64	1.32	0.00	0.00	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	28.59	1.30	1.95	0.32	0.00	0.32	0.00	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	34.95	1.94	2.43	0.49	0.00	0.00	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	39.20	1.78	1.19	1.19	0.00	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	38.79	2.26	2.26	0.00	0.38	0.00	0.00	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	37.74	1.45	2.18	1.45	0.00	0.00	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	51.40	2.51	1.25	3.76	0.00	1.25	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	60.13	2.31	2.64	1.48	0.00	0.16	0.16	0.33	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	28.66	0.00	0.00	1.36	0.00	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	47.05	2.87	2.26	0.75	0.00	0.30	0.60	0.00	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	40.18	1.07	2.68	1.61	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	40.05	3.02	3.40	1.32	0.00	0.19	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	43.83	3.74	1.87	1.60	0.00	0.27	0.27	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	34.14	0.00	2.93	2.93	0.00	0.00	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	37.48	1.82	2.32	1.33	0.00	0.00	0.33	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	0.00	7.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	35.40	0.00	0.00	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	33.96	2.40	2.06	1.03	0.17	0.34	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	33.49	4.37	2.43	1.46	0.00	0.97	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	37.57	4.17	3.04	2.66	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	31.50	3.63	0.00	2.42	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	34.77	2.85	3.42	1.14	0.00	0.00	0.00	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	40.40	2.35	3.63	1.07	0.00	0.43	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	34.84	2.58	4.39	2.32	0.00	0.26	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	27.68	2.35	1.88	0.47	0.00	0.00	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	38.59	2.57	1.61	1.29	0.00	0.00	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.11	1.43	3.57	1.43	0.00	0.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.40	1.17	1.75	1.17	0.00	0.58	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	41.85	1.51	2.11	1.20	0.00	0.00	0.30	0.30	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	38.02	2.38	1.19	1.19	0.00	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	35.09	0.51	4.58	1.02	0.00	0.00	1.02	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	44.57	2.29	2.55	1.02	0.00	0.51	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	29.23	1.91	2.54	0.64	0.00	0.00	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	39.27	1.73	1.29	0.00	0.43	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	44.67	2.12	1.69	0.64	0.42	0.00	0.00	0.42	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	34.80	1.45	3.19	1.16	0.00	0.58	0.29	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	31.18	0.94	1.89	0.94	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	48.15	1.70	2.71	0.68	0.00	0.00	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	4.63	9.27	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	27.46	2.11	0.00	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	44.81	2.36	2.57	1.07	0.21	0.43	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	40.91	3.61	5.41	0.60	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	26.24	1.46	1.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	55.63	1.84	2.76	2.07	0.00	0.23	0.00	0.23	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	0.00	5.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	38.39	1.02	1.27	2.80	0.00	0.00	0.25	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	43.56	0.83	1.86	2.48	0.21	0.00	0.21	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	37.94	1.84	2.75	1.84	0.00	0.31	0.00	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	36.81	2.39	2.39	0.48	0.48	0.00	0.48	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	38.36	3.55	3.55	1.33	0.22	0.00	0.89	0.44	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	3.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	28.25	1.66	2.77	2.22	0.00	0.00	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	41.84	3.18	3.18	1.32	0.00	0.26	0.00	1.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	26.90	1.45	1.82	1.82	0.36	0.00	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	140.13	1.84	0.98	0.12	0.00	0.25	0.25	0.37	0.00	0.25
Astrocyte - cerebellum, donor2	11580-120F5	131.28	1.03	4.62	1.03	0.00	0.51	0.68	0.68	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	108.44	1.89	6.29	0.84	0.00	0.21	0.42	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	111.90	2.09	2.09	1.05	1.05	1.39	0.35	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	84.93	0.97	2.26	0.49	0.00	1.29	0.49	0.65	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	108.29	2.68	4.18	1.49	0.30	0.89	0.00	0.30	0.30	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	71.91	7.11	5.73	1.72	0.34	0.92	0.00	0.46	0.11	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	78.05	6.01	6.26	3.13	0.13	0.75	0.38	0.00	0.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	61.45	5.69	4.32	2.73	0.23	0.68	0.34	0.34	0.11	0.00
Basophils, donor1	12241-129G9	1953.13	35.31	35.57	10.72	4.45	3.66	10.46	3.14	0.78	1.57
Basophils, donor2	12242-129H1	1188.46	25.26	23.09	6.13	4.33	5.05	3.97	1.08	0.72	0.36
Basophils, donor3	12243-129H2	1437.04	27.49	19.55	7.64	4.85	3.23	4.56	1.91	0.44	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	64.68	2.16	1.72	1.29	0.00	0.43	0.00	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	115.67	6.40	6.40	3.66	0.46	0.46	0.00	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	83.48	1.88	1.26	1.26	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	71.12	1.66	3.54	1.25	0.21	0.21	0.62	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	70.70	1.84	2.53	0.69	0.00	0.23	0.00	0.23	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	55.06	1.80	3.06	0.72	0.00	0.18	0.54	0.18	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	89.35	0.72	0.72	0.10	0.21	0.52	0.62	0.52	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	95.96	0.70	1.63	0.47	0.00	0.70	0.70	0.47	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	1401.57	11.83	13.43	3.20	0.96	3.20	2.88	1.92	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	2699.25	10.34	10.34	10.34	0.00	10.34	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	780.52	15.22	18.60	7.33	1.69	2.25	2.25	1.13	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	755.02	16.15	18.37	4.27	1.11	6.68	2.41	1.67	1.30	0.37
CD14+ Monocytes, donor3	11381-118B4	1152.13	32.49	27.44	10.54	3.73	6.37	4.39	1.98	0.66	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	74.16	1.98	7.08	0.57	1.13	0.57	0.57	0.57	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	73.92	1.90	8.34	1.14	0.38	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	78.57	2.30	5.92	1.97	0.33	0.00	0.00	0.00	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	268.28	10.26	11.71	3.04	0.72	1.73	2.89	1.45	0.87	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	227.21	6.64	9.66	2.11	1.21	1.21	1.51	0.91	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	290.19	10.66	9.48	3.79	0.71	2.13	3.08	1.90	0.00	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	218.29	4.18	4.85	2.01	0.50	1.17	2.01	0.67	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	165.05	3.86	2.76	0.83	0.55	0.28	0.28	0.00	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	281.90	5.21	4.21	0.74	0.74	1.49	1.49	1.24	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	202.46	2.94	2.94	1.37	0.39	1.17	1.96	0.20	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	197.28	2.85	1.42	0.89	0.36	0.71	1.60	0.53	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	332.32	4.35	3.05	0.87	0.44	1.09	1.96	0.65	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	286.34	3.04	4.45	1.64	0.70	1.40	1.87	1.17	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	307.84	6.34	4.22	0.53	0.00	0.53	2.11	0.53	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	447.07	2.22	8.87	3.33	0.00	12.20	3.33	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	268.49	8.63	6.69	2.68	0.30	3.42	1.49	2.08	0.30	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	173.81	3.99	3.99	0.80	0.60	1.00	2.00	0.80	0.80	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	237.97	3.54	5.41	1.25	0.62	0.83	2.50	0.42	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	269.51	6.63	2.97	1.37	0.46	1.14	1.14	1.14	0.46	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	240.91	4.30	1.13	0.68	0.00	1.36	1.13	0.90	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	292.87	3.93	2.62	0.44	0.44	0.87	3.06	1.31	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	226.49	4.84	6.19	2.15	1.08	0.81	2.69	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	255.93	4.54	3.66	1.22	0.87	1.92	0.87	0.70	0.52	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	324.03	4.63	9.68	1.26	1.26	4.21	2.95	1.68	1.26	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	133.74	2.20	1.65	0.18	0.00	1.29	0.73	0.18	0.73	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	111.67	1.06	0.70	0.00	0.00	0.70	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	185.58	0.00	1.75	0.44	0.44	0.88	0.88	0.44	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	257.20	2.62	3.14	1.22	0.52	1.39	1.74	1.05	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	264.26	2.97	2.60	2.23	0.37	1.49	2.97	0.37	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	431.53	5.17	5.60	1.51	0.65	3.02	2.59	1.08	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	134.72	2.05	1.64	0.82	0.00	0.41	0.82	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	151.60	1.16	1.16	0.23	0.23	0.23	1.16	0.46	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	226.66	2.09	2.09	0.46	0.46	0.46	0.70	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	310.38	20.92	17.66	7.85	0.00	0.87	2.83	0.44	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	385.76	21.71	14.09	6.01	1.62	2.31	2.08	1.15	0.23	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	356.77	20.58	16.25	4.98	0.22	0.65	1.52	0.65	0.22	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	449.10	23.05	19.47	7.47	0.31	1.87	2.18	0.62	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	455.65	21.83	18.69	4.54	1.05	2.10	1.05	0.87	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	344.93	16.72	19.18	4.68	0.22	0.89	2.68	1.11	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	395.27	20.67	17.10	6.38	0.51	1.02	1.02	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	335.06	25.47	15.37	6.37	0.22	2.42	1.98	1.10	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	394.77	22.53	13.47	6.32	0.21	0.84	1.68	0.84	0.21	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	420.69	2.03	16.26	4.06	0.00	0.00	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	381.70	3.39	16.27	1.36	0.00	2.03	2.71	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	394.56	7.25	15.53	1.04	2.07	1.04	3.11	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	759.05	9.06	8.53	2.13	0.00	0.53	2.67	1.07	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	513.02	8.04	23.59	2.14	0.54	1.07	0.54	3.22	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	424.67	6.32	7.02	2.11	1.40	0.00	0.00	1.40	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	449.44	8.63	18.82	1.57	0.00	1.57	0.00	2.35	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	470.63	7.91	14.50	1.32	0.00	0.00	2.64	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	2532.27	58.35	35.34	12.33	18.90	14.79	23.84	10.68	5.75	1.64
CD19+ B Cells, donor2	11624-122B4	1900.62	74.72	42.07	12.33	6.53	20.31	15.96	10.88	2.90	2.90
CD19+ B Cells, donor3	11705-123B4	2356.02	73.20	36.85	10.10	14.64	17.67	9.59	14.64	1.01	3.53
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	236.78	12.53	11.72	5.25	0.40	1.62	2.02	0.81	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	226.51	8.79	8.79	3.99	0.00	0.80	0.00	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	1095.42	12.05	12.05	4.02	1.00	3.01	5.02	3.01	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	1763.52	11.24	7.30	3.93	0.56	1.12	0.56	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	495.25	4.88	7.52	2.25	0.38	1.50	1.88	0.75	0.00	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	529.43	7.67	9.47	3.38	0.90	1.58	1.35	0.90	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	2427.63	38.92	15.71	8.93	5.71	9.28	8.21	7.14	0.71	0.71
CD4+ T Cells, donor2	11306-117C1	2390.05	42.25	26.94	13.47	5.51	22.66	22.05	14.08	4.29	1.22
CD4+ T Cells, donor3	11382-118B5	2334.72	40.56	30.50	10.67	6.40	20.43	11.28	11.28	2.74	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	246.30	7.15	8.68	3.06	0.26	0.77	1.02	0.77	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	240.77	6.29	10.33	1.57	0.90	1.35	1.57	0.67	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	269.06	14.37	13.22	3.74	0.57	0.86	0.86	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1979.33	18.02	18.96	6.64	1.42	6.64	4.27	4.74	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1653.27	9.13	13.34	2.81	0.70	6.32	5.62	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	1156.97	9.89	16.48	6.59	6.59	6.59	6.59	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	255.07	9.39	10.55	3.47	0.58	1.45	0.58	1.01	0.58	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	285.88	13.56	15.59	5.08	0.51	2.37	1.19	1.02	0.51	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	259.86	16.12	12.09	5.64	0.81	1.93	0.97	0.97	0.32	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1106.85	22.86	20.62	3.59	2.24	4.93	6.72	3.59	0.90	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1015.67	13.28	26.55	3.84	0.70	2.80	2.45	1.05	0.35	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	896.24	13.64	28.16	6.16	2.20	6.16	5.72	2.20	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	298.94	9.70	7.17	2.95	2.95	3.37	2.11	1.26	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	278.83	10.60	13.92	7.06	0.62	1.87	1.45	0.62	0.62	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	288.02	14.03	14.37	4.68	1.34	1.67	0.67	1.34	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1688.71	12.24	13.60	4.35	1.36	7.07	5.98	2.99	0.54	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1190.34	8.04	9.65	2.14	0.54	6.43	5.36	2.68	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1027.52	8.97	16.14	1.79	1.79	7.17	5.38	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	290.94	10.94	11.87	4.26	0.37	1.67	2.23	0.74	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	271.85	13.21	13.21	3.90	0.87	1.95	0.87	1.30	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	321.11	11.56	19.75	5.67	2.94	0.84	1.68	1.05	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1486.48	13.65	17.70	6.57	0.51	2.53	2.02	2.53	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1538.91	15.60	18.63	2.17	1.73	2.60	3.03	1.30	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1209.39	13.07	13.07	4.36	0.87	8.72	6.97	3.05	0.44	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	333.54	8.41	16.33	0.49	0.99	0.49	0.99	0.99	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	285.26	4.62	15.69	1.85	0.00	0.00	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	266.60	12.56	18.15	2.79	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	460.53	5.54	12.18	0.28	0.28	0.28	0.55	0.83	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	298.89	5.64	10.80	1.96	0.25	0.74	0.74	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	318.78	9.24	16.94	1.54	0.00	0.00	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	335.56	7.88	16.12	1.79	0.36	1.07	0.72	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	307.47	6.92	9.69	5.54	0.00	2.77	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	2253.14	48.78	22.92	8.84	11.79	8.51	11.46	8.51	2.29	3.93
CD8+ T Cells, donor2	11307-117C2	1786.68	37.92	22.15	11.26	6.38	19.52	12.76	9.01	3.38	1.88
CD8+ T Cells, donor3	11383-118B6	2268.11	41.66	26.76	10.86	10.10	17.93	12.12	8.08	2.78	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	265.86	52.76	9.86	12.62	0.46	2.29	0.92	2.29	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	236.05	50.56	10.30	15.82	0.24	2.88	1.68	1.20	0.24	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	225.17	47.06	6.57	15.32	0.55	3.28	2.46	1.37	0.82	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	97.57	30.02	7.51	10.21	1.20	3.30	4.50	3.00	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	300.22	56.40	10.80	16.80	0.48	3.60	3.12	1.92	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	243.53	49.12	8.41	12.05	0.91	1.59	1.14	2.27	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	239.66	51.06	6.52	12.17	0.00	1.52	1.30	0.43	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	202.93	51.32	7.90	17.90	0.79	1.32	1.32	2.11	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	227.95	49.48	6.80	13.13	0.23	2.11	2.58	2.81	0.70	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	283.16	50.11	8.75	13.89	0.30	1.51	2.11	1.21	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	273.95	54.91	8.13	13.94	0.58	1.74	1.74	2.32	0.00	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	277.36	50.89	9.06	13.32	0.00	1.87	2.93	1.33	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	792.33	94.55	9.19	23.20	0.44	4.38	4.82	4.82	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	722.31	90.17	7.74	20.04	1.37	2.73	4.10	2.73	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	520.62	145.45	8.20	29.83	1.49	2.24	8.20	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	271.92	60.51	9.36	19.45	1.08	0.72	2.16	1.80	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	286.57	67.61	6.04	18.99	0.58	3.16	2.88	1.73	1.44	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	291.09	60.34	10.13	16.50	2.12	3.30	2.59	0.94	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	255.74	48.80	8.24	11.73	0.32	1.58	2.22	2.22	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	234.36	56.59	9.84	13.84	0.31	3.38	3.69	2.15	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	221.84	53.86	8.98	11.22	1.28	1.28	1.28	1.28	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	258.16	56.99	8.41	13.39	0.38	1.15	2.68	1.15	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	258.93	50.84	11.82	13.79	0.39	1.58	2.36	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	184.56	59.76	4.54	14.37	0.00	2.27	6.05	1.51	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	878.43	95.55	13.65	16.06	1.61	5.62	5.62	8.03	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	1001.58	93.72	20.28	20.28	0.70	5.60	6.99	4.90	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	1039.82	90.16	20.04	22.04	5.01	9.02	10.02	4.01	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	135.25	1.83	0.00	3.66	0.00	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	59.78	7.91	6.42	0.99	0.49	0.49	0.00	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	86.08	3.05	2.63	0.84	0.11	0.32	0.21	0.21	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	91.87	2.77	4.16	0.35	1.04	0.35	0.69	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	65.03	1.07	2.49	1.78	0.36	0.36	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	67.24	3.98	2.62	2.05	0.46	0.46	0.11	0.57	0.11	0.00
Chondrocyte - re diff, donor2	11339-117F7	17.91	2.69	0.90	0.00	0.00	0.00	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	110.40	4.45	4.04	1.21	0.00	0.40	0.00	0.81	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	213.34	3.79	2.52	1.61	0.11	1.49	0.80	0.69	0.34	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	146.86	2.14	4.92	2.14	0.00	0.64	0.64	1.28	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	195.49	7.70	3.98	3.72	0.35	1.86	0.80	1.86	0.27	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	329.57	7.98	8.34	2.38	3.12	1.47	0.92	1.10	0.37	0.09
Corneal Epithelial Cells, donor1	11526-119I5	66.97	3.73	5.05	1.10	0.00	0.00	0.66	0.22	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	43.23	0.00	2.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	48.31	2.81	3.58	1.53	0.00	0.26	0.51	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	65.87	13.54	4.95	6.27	0.00	0.83	0.17	0.50	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	78.54	16.09	6.62	5.36	0.00	0.00	0.00	0.63	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	89.72	17.25	6.90	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	74.30	16.20	5.29	7.78	0.43	0.97	0.32	0.22	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	985.64	33.14	53.98	16.06	1.71	5.12	2.39	1.71	1.02	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	891.17	33.95	30.03	11.10	1.31	3.92	1.31	4.57	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1111.14	25.17	38.72	7.74	0.48	0.48	1.45	1.94	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	80.22	1.67	3.00	0.33	0.00	0.00	0.50	0.67	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	29.93	1.17	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	71.83	1.98	3.11	1.13	0.00	0.00	0.85	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	61.73	0.39	3.93	0.39	0.00	0.39	0.79	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	44.50	2.04	0.87	0.58	0.00	0.00	0.00	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	84.23	1.41	3.53	0.24	0.00	0.47	0.24	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	50.84	1.23	3.68	1.05	0.00	0.18	0.35	0.00	0.53	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	69.38	0.89	2.88	1.11	0.00	0.89	0.66	0.44	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	64.81	1.22	4.56	0.91	0.30	0.30	0.00	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	74.70	1.69	1.41	0.56	0.28	0.56	0.28	0.28	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	141.14	4.16	3.27	0.59	0.59	0.59	0.59	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	55.71	2.08	3.64	0.52	0.00	0.00	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	92.30	3.69	6.52	1.42	0.85	0.71	0.00	0.43	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	76.42	0.00	2.00	0.40	0.40	0.00	0.00	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	93.82	2.10	0.52	1.05	0.00	1.05	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	59.27	1.99	3.11	0.99	0.62	0.87	0.25	0.25	0.12	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	45.19	1.74	3.91	1.09	0.22	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	59.96	2.93	3.42	1.71	0.12	0.00	0.37	0.00	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	56.88	2.28	4.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	61.47	2.10	3.49	0.70	0.00	0.00	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	64.06	0.94	2.98	0.63	0.00	0.16	0.16	0.16	0.00	0.00
Eosinophils, donor1	12244-129H3	1341.73	15.25	15.25	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	2566.16	49.51	37.96	9.90	3.30	9.90	0.00	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	4340.82	32.10	28.53	14.27	17.83	14.27	3.57	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	53.51	2.20	3.42	1.22	0.00	0.49	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	87.37	6.24	4.16	0.00	0.00	2.08	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	165.85	8.62	7.39	4.93	0.82	1.64	0.82	1.23	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	38.21	3.61	2.52	1.64	0.77	0.22	0.44	0.44	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	105.41	5.63	6.72	2.06	0.54	0.87	0.54	0.11	0.11	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	85.26	4.61	3.52	1.58	0.36	0.73	0.12	0.97	0.12	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	43.26	2.18	1.23	0.96	0.00	0.14	0.41	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	92.29	7.17	6.33	3.16	1.27	1.05	0.42	0.95	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	43.48	1.84	1.58	0.53	0.26	0.00	0.00	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	83.38	4.65	6.98	3.32	2.99	0.66	0.00	1.00	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	69.86	3.63	4.08	1.36	0.00	0.45	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	81.10	4.55	6.06	3.03	0.00	0.76	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	104.25	6.62	4.42	2.37	0.47	0.63	0.32	0.47	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	66.99	4.85	4.85	1.52	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	66.75	4.31	3.68	0.38	0.25	0.38	0.38	0.00	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	50.78	2.73	3.18	0.76	0.15	0.45	0.15	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	101.30	3.48	3.89	1.47	0.27	0.00	0.40	0.27	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	80.68	4.75	7.33	1.29	0.43	0.00	0.43	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	101.07	5.86	2.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	153.84	5.54	8.30	1.85	0.46	0.23	0.46	0.46	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	168.42	15.43	10.85	7.29	0.34	0.00	0.51	0.68	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	46.96	3.29	5.40	2.58	0.94	0.00	0.23	0.47	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	36.79	1.89	1.42	2.83	0.00	0.00	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	74.22	6.17	6.41	3.75	0.73	0.24	0.36	0.24	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	31.20	2.37	3.62	1.02	0.00	0.11	0.11	0.11	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	34.89	2.27	5.41	0.70	0.00	0.17	0.35	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	35.73	2.76	6.01	0.81	0.16	0.00	0.16	0.00	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	41.23	4.37	3.33	2.08	0.00	0.21	0.42	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	81.74	3.93	8.12	2.62	0.00	1.05	0.26	0.26	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	61.54	3.95	5.93	1.71	0.26	1.32	0.26	0.26	0.26	0.13
Fibroblast - Gingival, donor3	11394-118C8	58.69	4.45	6.77	0.77	0.48	0.29	0.29	0.29	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	137.13	10.39	12.47	3.12	1.04	1.04	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	95.33	9.87	8.99	3.52	0.35	0.53	0.35	0.18	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	41.62	2.34	4.52	2.34	0.31	0.16	0.31	0.16	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	52.87	5.81	6.76	2.70	0.14	0.27	0.27	0.14	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	112.92	11.65	12.00	4.59	0.35	0.00	0.71	0.35	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	58.35	6.87	5.12	3.80	0.15	0.44	0.15	0.29	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	53.04	2.45	4.23	0.55	0.14	0.41	0.14	0.00	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	57.48	2.85	4.28	1.32	0.11	0.11	0.22	0.22	0.00	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	61.34	6.16	9.39	2.93	0.59	0.29	0.15	0.00	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	123.70	8.16	8.16	5.44	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	89.53	7.46	10.45	4.48	0.00	0.00	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	127.47	5.91	12.45	4.01	0.21	0.84	0.00	0.42	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	130.78	5.83	11.66	4.17	0.83	0.00	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	53.15	6.99	6.99	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	80.88	7.28	5.32	2.52	0.28	0.28	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	75.92	6.50	5.68	2.84	0.41	0.41	0.41	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	59.91	11.98	3.99	7.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	101.26	0.00	5.96	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	66.15	3.88	5.82	1.75	0.19	0.39	0.39	0.00	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	57.79	3.64	6.22	1.52	0.15	0.91	0.15	0.15	0.15	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	37.94	1.84	2.45	1.53	0.00	0.00	0.31	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	53.81	4.96	4.20	1.53	0.38	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	59.40	4.05	4.86	2.43	0.00	0.54	0.54	0.00	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	116.67	10.67	8.70	5.10	0.12	0.58	0.46	0.35	0.35	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	71.18	1.88	2.98	1.55	0.00	0.55	0.22	0.11	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	134.72	13.61	8.94	3.86	0.20	0.20	0.81	0.81	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	57.47	4.01	4.01	1.34	0.00	0.00	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	79.07	2.37	3.95	1.98	0.00	0.40	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	52.59	0.60	1.39	0.79	0.00	0.00	0.20	0.20	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	64.12	3.02	4.09	0.89	0.18	0.00	0.00	0.18	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	56.96	1.97	3.35	1.77	0.00	0.39	0.39	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	30.69	2.71	1.50	0.90	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	67.69	3.13	3.45	0.86	0.11	0.32	0.22	0.22	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	80.73	2.53	2.28	2.02	0.00	0.25	0.25	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	81.05	3.61	3.28	1.97	0.00	0.33	0.49	0.16	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	42.91	1.80	1.80	0.80	0.00	0.20	0.00	0.00	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	58.37	2.31	2.61	0.70	0.60	0.40	0.10	0.00	0.10	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	70.72	1.81	0.91	1.21	0.00	0.30	0.00	0.60	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	72.24	2.73	4.39	0.75	0.41	0.75	0.25	0.50	0.08	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	138.30	6.67	5.13	2.05	0.17	0.00	0.17	0.68	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	55.83	2.30	2.30	1.97	0.00	0.00	0.99	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	64.66	2.02	1.92	0.96	0.32	0.53	0.21	0.00	0.11	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	69.33	3.54	3.54	1.69	0.00	0.84	0.17	0.17	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	48.46	2.20	5.18	1.10	0.63	0.63	0.31	0.16	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	77.57	0.87	8.72	0.87	0.87	0.00	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	50.97	1.39	1.56	1.04	0.17	0.00	0.00	0.00	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	72.87	1.56	1.30	0.78	0.52	0.26	0.00	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	45.23	3.07	2.04	0.77	0.00	0.26	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	109.47	0.77	1.53	0.00	3.06	0.00	0.00	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	94.43	0.64	1.91	0.64	0.00	0.64	0.64	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	171.16	1.71	1.71	0.29	1.71	0.57	0.86	0.86	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	308.57	1.10	4.96	0.55	4.41	1.38	0.55	2.21	0.28	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	347.06	1.83	4.79	0.68	2.74	1.83	1.83	1.83	0.46	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	238.15	2.18	2.77	0.40	2.18	0.40	1.19	0.99	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	267.24	1.06	6.08	1.32	5.02	1.32	0.79	1.32	0.53	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	497.37	2.28	6.85	1.63	3.91	0.65	0.65	1.96	1.30	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	189.71	2.65	2.21	0.44	0.44	0.44	0.00	0.88	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	103.73	1.13	1.55	0.85	0.28	0.57	0.28	0.71	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	124.99	1.97	2.96	0.49	0.74	0.99	0.12	0.49	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	65.28	1.07	0.54	1.07	0.54	0.81	0.27	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	170.23	3.96	4.71	1.36	0.12	1.36	0.25	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	147.98	2.21	4.01	0.69	0.83	0.97	0.14	0.83	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	100.02	2.64	2.64	0.41	0.00	0.41	0.41	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	116.83	5.02	4.56	2.05	0.46	0.46	0.23	0.23	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	117.84	5.48	5.23	1.74	0.62	0.75	0.37	0.87	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	131.80	6.99	7.21	3.06	0.44	0.66	0.44	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	116.42	4.43	4.73	1.48	0.59	0.30	0.30	1.48	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	127.96	4.45	2.23	0.79	0.64	0.79	0.16	0.79	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	119.53	4.02	4.24	1.79	0.89	0.45	0.22	0.67	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	107.67	2.42	2.22	0.40	0.40	0.40	0.00	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	118.41	2.88	2.37	0.68	1.02	1.02	0.34	0.68	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	161.03	4.34	2.75	1.42	0.09	0.71	0.35	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	183.03	2.29	3.85	0.73	0.42	0.42	0.52	0.31	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	167.87	2.22	4.27	0.17	0.00	0.34	1.02	0.51	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	117.18	1.99	2.32	0.55	0.55	0.66	0.00	0.22	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	139.27	3.08	2.83	1.58	0.25	0.33	0.17	0.42	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	133.33	3.27	3.06	0.82	0.00	0.61	0.20	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	101.91	0.83	3.09	0.83	0.21	0.62	0.00	0.83	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	130.28	1.96	2.19	0.35	0.92	0.69	0.00	0.35	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	89.22	1.00	3.17	0.67	0.83	0.67	0.33	0.33	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	106.03	2.87	5.51	0.66	1.10	0.22	0.00	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	144.76	0.86	3.57	0.61	1.23	1.11	0.25	0.98	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	93.37	2.92	1.62	0.32	0.49	0.81	0.16	0.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	142.08	0.96	2.89	0.00	0.64	1.60	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	111.53	1.61	2.84	1.04	0.85	0.47	0.19	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	80.83	3.01	4.59	0.95	0.47	0.32	0.32	0.63	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	95.79	2.43	3.95	0.61	0.00	0.61	0.30	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	100.15	1.67	3.35	0.10	0.31	0.52	0.31	0.00	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	81.89	1.32	2.85	1.76	1.32	0.22	0.22	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	82.76	1.12	4.77	0.84	0.28	0.56	1.12	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	62.50	1.57	2.59	0.19	0.19	0.37	0.00	0.19	0.28	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	54.55	1.60	2.94	1.34	0.00	0.53	0.27	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	44.83	2.60	4.28	0.77	0.15	0.31	0.31	0.31	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	69.69	1.30	4.40	0.39	0.13	0.52	0.39	0.26	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	46.08	1.90	5.15	0.54	0.00	0.27	0.27	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	73.37	2.40	2.95	1.11	1.11	1.11	0.74	0.55	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	103.08	1.54	4.82	0.22	0.22	1.10	0.66	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	72.40	0.99	3.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	91.68	2.37	3.30	1.85	0.26	1.06	0.40	0.40	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	103.70	3.63	2.62	0.81	0.81	0.40	0.20	0.40	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	72.69	3.30	2.80	0.51	0.25	0.25	0.76	1.52	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	89.78	0.20	0.60	0.20	0.00	0.40	0.20	0.40	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	115.25	0.77	0.92	1.69	0.92	0.31	0.46	0.46	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	100.86	0.61	2.25	0.41	0.41	0.61	0.20	0.82	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	128.61	0.00	1.88	0.31	0.00	0.63	0.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	92.11	0.00	0.85	0.28	0.28	0.00	0.57	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	73.79	0.00	1.38	0.00	0.46	0.00	0.46	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	116.32	0.00	2.47	0.00	2.47	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	95.15	1.55	1.55	1.16	0.00	1.55	0.39	1.16	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	83.43	1.60	1.60	0.00	0.00	0.00	0.00	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	114.76	3.48	3.48	0.00	1.74	0.00	1.74	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	80.39	0.00	3.58	0.65	0.33	0.98	0.98	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	92.24	1.24	2.06	0.41	0.00	0.00	0.41	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	129.96	0.00	0.00	0.00	0.00	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	64.60	0.56	0.84	0.28	0.56	0.00	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	76.15	1.96	2.61	1.31	0.00	1.96	0.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	86.40	0.84	2.52	0.00	3.36	0.00	1.68	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	92.24	0.95	3.18	0.64	0.64	0.00	0.00	0.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	67.93	1.36	1.36	0.34	0.00	0.34	0.68	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	75.17	0.00	4.18	0.00	0.00	4.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	122.56	1.72	5.73	2.29	0.00	0.57	1.15	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	98.27	1.18	6.22	0.59	0.00	1.18	0.30	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	110.12	0.00	3.39	0.00	0.00	0.00	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	94.85	1.66	3.73	0.41	0.00	0.41	0.00	1.24	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	77.55	0.69	2.99	1.38	0.00	0.69	0.23	0.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	94.83	0.00	10.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	85.72	0.77	1.15	0.00	0.77	0.77	0.38	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	67.80	1.63	2.93	0.65	0.33	1.30	0.33	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	120.39	3.34	5.35	0.67	0.67	0.67	0.67	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	99.40	1.93	5.78	0.39	0.00	0.39	1.16	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	124.27	2.40	3.08	0.34	0.00	0.68	1.03	0.68	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	245.99	4.97	12.42	2.48	2.48	0.00	4.97	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	134.95	1.42	5.19	1.42	0.47	0.94	1.89	2.83	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	129.75	1.21	10.86	1.81	0.60	0.00	1.81	1.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	128.69	1.53	6.61	1.53	1.53	1.02	1.02	0.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	121.65	1.99	1.99	0.40	0.80	0.40	0.40	0.80	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	130.25	3.45	6.91	0.99	0.49	0.00	0.49	1.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	184.15	3.54	9.44	1.18	0.00	0.00	3.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	127.19	2.92	4.08	0.00	0.58	1.75	2.92	1.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	236.12	4.39	6.14	1.76	2.19	1.76	2.19	2.19	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	327.21	3.39	7.63	2.54	0.00	3.39	5.09	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	137.89	0.60	4.18	0.60	0.00	0.60	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	117.92	1.46	1.94	0.49	0.00	0.49	0.97	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	46.79	2.28	7.99	3.42	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	69.03	7.48	7.07	4.16	0.00	0.42	0.00	0.00	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	60.72	9.00	19.12	4.50	2.25	1.12	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	81.19	8.88	4.12	2.54	0.00	0.32	0.63	0.00	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	51.80	2.92	3.34	1.25	0.42	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	99.45	5.22	4.87	3.13	0.00	1.16	0.70	0.46	0.00	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	103.31	6.08	4.56	3.04	0.00	0.68	0.51	0.17	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	80.76	5.69	3.41	3.87	0.00	0.23	0.46	0.46	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	81.00	4.37	2.95	3.17	0.22	0.87	0.44	0.33	0.11	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	91.77	5.16	2.36	2.36	0.00	0.64	0.43	0.43	0.43	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	72.12	4.74	2.80	1.72	0.43	0.22	0.43	0.00	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	97.64	5.11	2.37	2.24	0.25	1.12	0.12	0.25	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	84.75	5.15	3.43	3.09	0.00	0.69	0.51	0.51	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	80.09	5.45	1.28	1.28	0.00	1.60	0.00	0.32	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	80.59	0.56	3.92	0.56	0.00	0.56	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	89.59	6.06	8.66	2.60	0.43	0.43	0.00	1.30	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	0.00	0.00	2.64	0.00	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	178.83	6.70	6.70	4.59	0.35	0.00	0.71	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	134.40	6.54	11.62	5.09	0.00	2.18	1.45	0.73	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	77.63	4.02	4.37	1.40	0.00	0.52	0.52	0.00	0.00	0.00
Hepatocyte, donor1	11523-119I2	78.69	1.21	3.63	1.21	0.00	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	105.58	2.15	4.31	3.23	0.00	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	140.50	3.68	4.91	0.61	0.00	0.00	0.00	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	184.71	2.61	3.26	3.92	0.65	0.65	1.31	0.65	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	133.36	2.80	1.57	0.17	0.87	0.70	0.70	1.05	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	79.17	3.29	4.39	2.61	0.00	0.55	0.27	0.14	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	503.05	31.84	12.74	0.00	0.00	6.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	260.34	13.35	13.35	0.00	6.68	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	216.67	0.00	0.00	0.00	0.00	0.00	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	328.10	18.00	11.08	2.77	2.77	1.38	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	242.76	5.01	2.50	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	201.76	11.87	11.87	0.00	0.00	11.87	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	363.93	17.94	20.50	2.56	0.00	5.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	319.95	9.14	22.85	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	436.94	30.86	11.37	9.75	0.00	3.25	0.00	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	326.79	20.01	3.33	5.00	0.00	3.33	0.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	228.73	7.26	7.26	0.00	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	481.74	27.79	17.21	6.62	0.00	5.29	1.32	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	257.21	14.41	12.20	5.54	0.00	4.43	1.11	2.22	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	225.25	5.24	20.95	0.00	0.00	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	304.22	16.38	8.82	8.19	0.63	1.26	1.26	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	289.22	13.92	10.83	1.55	0.00	0.00	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	146.35	43.90	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	428.97	16.80	9.04	5.81	3.23	4.52	2.58	0.65	1.29	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	350.96	19.32	9.66	9.66	0.00	1.61	0.00	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	346.50	0.00	11.95	35.84	11.95	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	415.59	16.30	9.78	3.26	0.00	4.89	1.63	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	484.88	11.75	9.66	6.72	0.00	2.10	1.26	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	215.59	0.00	14.37	0.00	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	348.80	14.47	8.84	4.82	1.61	0.80	0.00	0.80	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	248.36	11.08	3.69	2.77	0.00	1.85	0.00	0.92	0.00	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	150.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	235.07	9.44	6.14	5.19	0.00	0.94	0.47	0.94	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	185.93	10.88	6.35	0.91	1.81	1.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	250.62	14.74	14.74	0.00	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	309.92	22.60	13.99	7.53	0.00	3.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	294.75	13.98	6.35	3.81	1.27	0.00	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	131.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	325.85	18.49	9.57	5.74	0.00	1.91	0.00	1.28	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	216.90	10.94	1.82	3.65	1.82	1.82	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	47.41	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	329.90	17.85	6.43	5.71	0.00	3.57	0.71	1.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	209.05	0.00	16.59	6.64	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	187.64	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	154.64	7.41	5.25	3.40	0.93	0.93	0.62	0.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	238.82	5.27	8.78	7.02	0.00	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	160.30	6.29	6.29	3.14	0.00	0.00	3.14	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	274.68	13.21	10.43	2.78	0.00	6.26	0.70	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	185.90	17.70	13.28	2.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	191.28	0.00	12.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	211.88	10.46	8.72	3.49	0.00	0.87	1.74	1.74	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	209.23	2.25	4.50	2.25	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	170.74	17.42	17.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	211.22	10.67	7.47	2.13	0.00	1.07	1.07	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	358.83	13.85	8.31	4.16	0.00	1.39	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	247.92	14.25	17.10	2.85	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	287.17	20.25	8.28	5.52	0.00	0.92	1.84	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	239.00	3.03	3.03	0.00	0.00	3.03	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	167.63	0.00	18.63	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	212.53	4.23	3.17	2.11	0.00	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	63.81	1.96	2.12	0.57	0.08	0.98	0.16	0.08	0.00	0.16
Keratinocyte - epidermal, donor2	11349-117G8	65.59	1.17	2.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	43.54	1.23	2.65	0.57	0.09	0.19	0.09	0.00	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	83.78	1.70	3.52	1.02	0.00	0.45	0.23	0.11	0.00	0.23
Keratocytes, donor1	11527-119I6	140.28	5.50	11.35	0.34	0.34	0.69	1.72	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	38.67	2.34	11.72	3.52	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	82.99	4.35	6.13	3.16	0.59	0.99	0.00	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	175.83	2.20	0.00	0.00	0.00	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	65.80	0.00	5.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	126.87	1.96	2.65	1.04	0.12	0.35	0.35	0.12	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	82.95	4.64	3.73	3.03	0.10	0.20	0.10	0.20	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	120.47	2.13	2.61	0.83	0.12	0.59	0.47	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	140.10	2.51	2.79	1.40	0.28	0.28	0.28	0.84	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	62.81	1.26	1.73	0.47	0.00	0.31	0.31	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	82.27	2.69	2.15	2.69	0.00	0.54	0.54	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	109.05	3.78	2.21	1.26	0.00	0.32	0.00	1.26	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	74.61	1.19	1.94	0.97	0.32	0.43	0.65	0.32	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	87.41	2.46	3.28	1.23	1.64	0.82	0.82	0.41	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	200.74	3.03	4.05	2.28	0.76	1.52	0.25	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	106.13	2.82	1.69	0.70	0.14	1.13	0.42	0.28	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	138.83	2.77	2.77	1.19	0.00	0.79	0.79	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	225.29	4.07	2.52	2.71	0.39	0.78	1.16	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	119.61	2.22	1.85	0.93	0.37	0.74	0.74	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	141.46	4.18	2.09	1.39	0.35	0.70	0.70	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	193.92	4.53	3.82	1.43	0.24	0.24	1.19	0.95	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	105.21	2.20	1.79	0.41	0.14	0.96	0.69	0.55	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	159.83	4.00	3.08	0.62	0.31	0.92	0.00	1.54	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	191.41	2.18	2.81	1.56	0.00	1.25	0.94	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	101.74	1.83	1.65	0.18	0.00	0.91	0.00	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	142.83	2.63	2.30	1.32	0.00	0.33	0.66	1.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	209.99	3.51	2.34	1.46	1.17	0.88	0.88	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	98.82	1.49	2.74	1.00	0.00	0.75	1.24	1.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	176.04	7.27	2.91	2.91	0.48	0.97	0.48	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	254.75	5.66	3.23	1.62	0.27	0.00	0.81	1.08	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	104.30	2.57	0.76	0.91	0.76	0.61	1.06	0.91	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	142.05	4.67	2.07	1.04	1.56	1.04	1.04	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	272.63	4.40	2.51	1.47	0.21	0.63	1.47	0.63	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	114.13	2.41	1.50	1.05	0.75	0.60	0.90	0.60	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	120.38	2.75	3.44	0.00	0.00	0.00	1.38	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	208.09	4.70	2.82	2.07	0.00	0.56	0.56	1.13	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	105.61	2.33	2.33	0.53	0.00	0.64	1.27	0.53	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	120.66	4.85	2.42	0.97	0.00	1.94	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	195.50	5.62	3.97	2.65	0.33	0.33	0.33	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	95.77	1.24	2.35	0.12	0.12	0.50	0.74	0.50	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	68.49	3.70	2.96	0.74	0.37	1.11	0.37	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	204.34	3.46	2.72	1.48	0.74	1.48	1.24	1.24	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	113.84	2.89	2.47	1.24	0.69	0.82	0.55	0.27	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	110.64	2.89	3.54	0.32	0.00	0.32	0.64	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	189.60	4.26	2.43	0.91	0.30	1.22	0.61	1.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	99.10	1.12	1.26	1.26	0.00	0.98	0.56	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	103.11	4.98	2.49	0.00	0.36	0.71	1.07	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	271.47	7.76	1.94	3.88	1.45	0.97	0.97	2.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	95.08	2.33	1.40	0.62	0.16	0.93	0.31	0.16	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	85.23	3.22	2.51	0.72	0.36	0.36	1.07	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	164.32	2.61	5.23	0.98	0.33	0.00	0.33	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	77.22	1.65	2.35	0.71	0.24	0.94	0.24	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	103.83	2.85	2.60	2.23	0.62	0.12	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	206.44	4.35	4.10	1.79	0.26	0.51	0.51	0.26	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	61.76	1.79	2.69	0.30	0.60	0.30	0.30	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	448.67	20.39	9.06	2.27	0.00	4.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	214.80	20.71	6.14	6.90	0.00	1.53	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	158.84	13.36	8.16	8.16	2.23	2.97	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	208.18	20.73	12.27	15.23	0.00	3.81	0.85	0.42	1.69	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	229.28	17.58	13.36	5.63	0.70	4.22	0.70	1.41	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	198.93	21.48	8.41	3.74	0.00	0.93	2.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	176.74	18.55	8.24	6.18	1.03	1.55	4.12	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	209.34	21.41	7.14	3.57	0.00	5.95	2.38	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	301.29	15.15	7.92	8.37	0.23	0.90	1.36	1.36	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	167.52	12.21	6.11	5.82	0.29	3.49	0.87	0.58	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	177.82	14.86	5.85	5.85	0.90	2.25	1.35	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	343.32	21.14	8.67	10.16	1.08	1.49	1.22	1.08	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	233.65	20.54	13.87	8.22	1.54	4.11	1.03	1.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	200.42	18.35	13.06	9.17	0.71	1.76	0.71	0.71	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	159.25	15.33	6.66	8.00	1.33	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	248.07	21.90	12.23	11.21	0.51	3.06	4.08	1.53	0.00	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	189.70	14.94	10.14	7.47	0.80	0.80	1.87	1.07	0.53	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	217.48	14.17	8.88	7.37	0.76	1.70	0.76	1.70	0.76	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	272.42	19.63	7.98	13.50	1.84	3.68	1.84	1.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	275.61	23.65	13.05	13.05	0.00	2.45	3.26	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	202.83	16.45	6.46	7.50	1.04	1.87	1.04	0.83	0.62	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	185.25	15.41	8.13	4.48	0.56	2.80	1.96	2.24	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	269.95	13.39	13.39	8.24	4.12	0.00	0.00	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	235.44	16.84	8.71	6.68	0.87	2.90	3.19	2.03	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	166.80	16.74	9.27	4.78	1.49	1.79	1.20	1.79	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	205.26	17.15	7.75	7.75	1.11	0.00	0.55	1.66	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	288.80	24.74	11.67	9.90	0.35	4.95	1.41	1.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	186.60	16.60	8.48	5.90	0.37	1.84	2.95	1.11	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	279.76	29.93	9.21	5.76	1.15	1.15	3.45	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	234.09	25.33	9.59	11.51	3.45	1.92	0.77	1.15	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	195.32	18.68	8.49	11.32	0.00	3.96	3.96	0.00	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	210.86	22.15	10.67	4.92	0.00	0.00	1.64	1.64	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	269.77	23.50	14.91	11.30	1.36	2.71	1.81	1.36	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	184.56	17.24	10.05	12.21	0.72	2.87	2.15	2.87	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	211.37	28.38	8.96	10.46	1.49	0.75	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	282.04	21.55	11.52	10.03	0.74	4.09	1.86	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	168.42	21.11	7.32	6.03	0.00	2.58	0.43	0.86	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	196.09	13.70	9.42	8.56	0.86	0.00	0.86	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	206.24	21.99	11.33	11.99	0.67	2.33	2.00	1.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	253.39	30.17	10.86	11.46	1.21	1.81	3.02	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	227.52	19.20	11.38	8.53	2.84	0.71	0.71	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	238.54	17.53	6.87	10.66	1.72	2.41	1.72	1.72	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	245.29	22.54	9.12	12.35	1.61	3.22	3.22	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	216.15	26.26	6.06	10.77	2.69	2.02	2.69	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	240.02	23.71	11.48	11.85	0.37	4.82	1.11	1.85	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	444.24	19.77	13.96	8.14	4.65	3.49	0.00	1.16	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	236.93	23.27	8.46	9.52	0.00	0.00	0.00	3.17	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	256.10	27.61	10.80	8.80	0.80	2.40	2.80	1.60	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	262.40	21.81	16.72	9.45	1.45	0.00	1.45	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	317.34	25.30	14.56	6.90	0.77	1.53	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	276.73	20.72	11.35	12.83	1.97	2.96	1.97	1.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	240.88	25.41	12.23	8.47	0.94	3.76	0.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	306.22	28.16	11.06	8.55	1.51	3.52	2.01	0.50	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	253.25	27.49	11.72	10.36	1.35	2.25	0.45	2.25	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	192.76	17.21	18.93	12.05	0.00	3.44	3.44	3.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	261.86	21.82	10.24	10.24	1.78	1.34	1.34	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	260.03	27.76	12.90	9.78	0.39	3.13	2.74	2.74	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	234.87	20.45	10.56	6.60	1.32	3.30	1.98	0.66	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	329.52	35.81	18.68	14.01	2.08	0.52	2.59	1.04	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	328.61	28.44	17.07	11.38	1.31	3.94	2.63	0.88	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	250.48	22.36	12.86	10.62	1.12	2.80	1.68	1.68	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	312.68	27.82	14.13	14.57	0.44	4.42	2.65	0.88	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	263.83	26.23	15.81	8.49	1.54	1.93	1.93	1.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	240.01	26.84	12.15	12.66	2.03	1.01	1.52	1.01	0.00	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	305.67	29.80	7.69	11.53	0.96	2.40	2.88	0.96	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	273.11	21.87	9.54	13.91	2.39	3.58	2.78	1.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	275.25	29.17	17.01	10.33	0.61	1.22	3.04	3.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	208.89	18.68	6.92	6.23	2.08	3.46	1.38	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	280.43	32.68	16.72	13.68	1.52	3.80	3.04	1.52	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	277.32	27.89	15.49	10.33	2.58	2.07	2.58	1.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	281.16	22.98	10.88	12.09	0.00	1.21	1.21	1.21	2.42	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	281.72	30.42	8.56	11.73	1.58	2.85	1.58	3.80	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	290.00	29.32	14.93	12.79	0.53	2.13	0.53	1.60	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	273.54	21.84	8.05	9.77	2.30	1.15	0.00	1.72	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	321.91	36.00	14.91	14.91	1.54	6.17	4.63	2.06	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	260.31	30.42	14.85	12.73	1.41	4.95	0.71	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	258.21	26.67	6.81	8.51	0.57	1.70	1.13	0.00	0.57	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	324.50	31.62	8.32	19.55	2.08	4.58	3.33	1.25	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	245.88	22.71	9.40	13.31	0.78	4.70	2.35	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	217.12	17.95	9.19	9.19	2.09	1.25	1.25	0.84	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	275.07	28.81	12.08	12.55	1.39	2.79	0.46	1.39	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	173.95	20.74	8.70	16.73	0.67	3.35	4.01	2.68	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	171.62	19.78	6.95	8.02	1.07	0.53	1.07	2.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	223.46	22.63	6.47	10.10	2.02	4.04	0.00	2.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	186.31	20.19	9.18	18.36	0.92	0.00	0.92	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	202.72	19.56	12.45	4.45	0.89	0.89	1.78	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	204.01	18.81	9.69	9.12	1.14	2.28	1.14	2.28	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	200.16	16.87	7.67	11.50	0.00	3.07	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	130.78	13.68	7.11	2.19	0.55	0.00	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	194.22	16.04	10.25	6.24	0.00	3.56	1.34	1.34	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	266.97	13.26	8.84	8.32	1.56	2.08	0.52	0.52	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	176.39	13.26	6.63	4.64	1.33	0.66	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	234.88	14.55	12.47	6.24	0.00	0.00	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	50.60	2.51	3.87	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	56.52	6.79	2.20	2.02	0.00	0.18	0.00	0.00	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	61.48	4.98	4.72	2.10	0.26	0.52	0.52	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	64.78	2.66	1.59	2.66	0.00	0.00	1.06	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	76.69	2.54	1.90	1.58	0.32	0.63	0.00	0.00	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	61.99	1.11	1.95	1.11	0.00	0.28	0.14	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	76.43	2.69	2.09	0.90	0.00	0.30	0.20	0.00	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	71.23	1.45	2.61	0.58	0.00	0.58	0.29	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	54.87	2.24	5.49	0.75	0.00	0.50	0.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	39.32	20.34	2.71	4.75	10.17	2.03	27.80	12.20	0.00	1.36
Mast cell, donor1	11563-120D6	335.02	15.03	15.90	11.57	5.52	0.76	1.19	1.30	0.22	0.11
Mast cell, donor2	11565-120D8	4839.18	83.80	50.22	25.85	98.96	16.64	27.34	22.29	7.13	3.86
Mast cell, donor3	11566-120D9	4305.96	64.16	40.75	22.96	119.99	17.33	35.12	23.41	6.08	5.18
Mast cell, donor4	11567-120E1	3870.22	66.31	50.88	23.05	91.84	16.84	26.95	13.12	3.37	2.84
Mast cell, expanded and stimulated, donor5	11940-126A5	164.57	9.20	12.64	3.44	2.44	1.77	0.33	0.67	0.11	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	176.27	19.85	17.51	9.34	2.92	1.17	2.33	2.33	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	191.47	4.36	11.36	2.29	6.54	0.92	0.92	1.38	0.11	0.69
Mast cell, expanded, donor8	11941-126A6	369.21	11.72	28.12	6.53	9.87	2.68	1.84	2.85	0.33	0.33
Melanocyte - dark, donor1	11502-119F8	77.91	1.29	1.89	0.40	0.00	0.10	0.30	0.10	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	48.80	5.19	4.15	0.69	0.00	0.00	0.35	0.35	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	117.28	3.11	1.81	0.94	0.29	0.22	0.22	0.22	0.07	0.00
Melanocyte - light, donor1	11274-116H5	169.72	7.05	5.41	2.82	5.88	0.00	0.24	1.18	0.24	0.24
Melanocyte - light, donor2	11351-117H1	150.14	4.09	5.46	0.00	1.36	1.36	1.36	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	106.67	4.34	6.07	1.73	0.87	0.87	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	81.32	3.12	2.39	1.25	0.83	0.62	0.10	0.10	0.21	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	86.87	2.96	2.69	0.54	0.27	0.00	0.27	0.27	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	107.41	1.87	3.75	0.54	0.27	0.80	0.00	1.61	0.27	0.00
Meningeal Cells, donor1	11493-119E8	83.74	2.98	3.85	1.24	0.00	0.12	0.25	0.00	0.00	0.12
Meningeal Cells, donor2	11573-120E7	85.83	3.52	3.96	0.44	0.88	0.44	0.00	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	61.21	1.63	1.79	0.98	0.16	0.41	0.24	0.16	0.00	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	148.85	4.56	5.42	3.71	0.29	0.00	0.57	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	100.33	5.23	3.82	2.31	0.00	1.21	0.81	0.50	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	251.01	26.28	17.08	9.20	0.00	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	44.48	5.23	5.23	6.54	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.86	2.15	2.87	1.44	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	112.03	7.62	4.24	1.27	0.42	0.21	1.06	0.85	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	78.92	5.53	5.53	1.51	1.51	0.50	1.01	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	110.10	7.69	7.69	3.08	0.00	0.44	0.44	0.66	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	73.06	3.65	7.31	3.65	0.00	0.73	1.46	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	83.89	6.96	5.73	6.34	0.20	0.41	0.61	0.41	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	173.00	6.23	4.99	2.35	0.14	0.28	0.55	0.69	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	171.36	10.41	11.90	2.97	0.00	0.74	0.74	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	193.68	8.03	4.61	3.29	0.39	0.92	0.13	0.53	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	157.57	10.09	8.01	3.26	0.00	0.89	0.59	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	109.77	2.34	9.34	2.34	0.00	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	73.65	8.97	5.12	1.28	0.00	0.00	1.28	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	50.69	3.90	2.84	0.71	0.35	0.00	0.00	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	198.89	7.51	6.88	1.56	0.31	0.00	0.00	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	38.46	1.45	6.53	0.73	0.00	0.00	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	89.36	4.51	1.59	1.06	0.53	1.06	1.33	0.27	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	116.11	1.50	2.00	4.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	71.98	4.77	2.75	2.46	0.58	0.94	0.29	0.22	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	163.39	12.15	9.45	6.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	62.55	5.66	5.17	2.46	0.74	0.74	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	59.78	11.19	2.94	3.83	0.29	0.00	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	103.71	10.37	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	49.90	5.58	1.86	0.93	0.00	0.31	0.62	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	46.26	6.02	2.90	1.66	0.00	0.00	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	138.96	2.32	4.63	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	87.59	7.51	4.75	2.00	0.50	1.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	55.86	6.52	1.86	3.72	0.00	0.00	0.47	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	408.79	19.47	19.47	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	88.40	7.52	4.67	2.24	0.20	0.41	0.61	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	60.19	5.54	3.56	2.38	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	436.13	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	53.98	6.19	3.54	0.00	0.00	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	51.67	7.60	3.04	2.28	0.00	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	98.69	7.90	6.58	6.58	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	76.61	5.52	5.09	1.70	0.21	0.42	0.21	0.21	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	53.41	10.13	4.60	2.76	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	71.24	7.15	1.79	2.09	0.00	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	68.74	16.77	1.68	1.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	475.29	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	64.73	4.27	1.76	0.50	0.50	0.50	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	42.78	5.23	2.61	0.71	0.71	0.24	0.24	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	57.50	6.08	2.21	2.21	0.00	0.00	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	39.83	3.45	1.61	1.15	0.46	0.23	0.69	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	34.92	4.42	0.63	1.89	0.00	0.00	0.63	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	32.61	4.28	1.02	1.02	0.20	0.00	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	35.18	3.00	3.00	0.43	0.00	0.00	0.21	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	33.34	4.00	1.11	1.56	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	134.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	29.13	3.72	0.44	1.31	0.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	30.42	4.56	2.03	2.03	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	59.65	1.66	0.00	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	36.69	1.36	1.36	1.36	0.27	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	31.76	3.23	1.47	1.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	33.80	3.27	2.18	4.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.51	4.32	3.36	1.44	0.00	0.48	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	31.22	4.00	2.80	2.40	0.00	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	69.93	13.71	5.48	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	31.04	6.51	1.50	0.50	0.50	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	44.85	12.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	24.09	1.75	1.31	1.31	0.00	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	65.12	13.24	5.52	4.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	54.43	7.68	4.48	3.84	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	24.30	4.46	4.21	0.99	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	47.32	10.44	2.09	2.78	0.00	0.00	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	130.38	4.42	15.47	4.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	42.39	6.50	10.26	1.37	0.00	0.68	0.00	0.68	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	45.51	14.88	7.44	4.38	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	77.06	8.88	11.01	3.55	0.00	0.00	0.00	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	45.73	9.82	6.45	2.24	0.00	0.84	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	39.48	16.63	5.40	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	86.25	12.82	15.15	7.58	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	46.46	10.86	11.76	1.51	0.00	0.00	0.30	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	48.42	13.36	3.76	6.68	0.00	0.42	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	202.13	43.31	28.88	14.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	63.73	9.24	8.31	2.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	58.05	19.35	5.12	4.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	59.56	12.16	9.81	4.28	0.14	0.00	0.28	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	61.16	11.40	10.11	4.66	0.52	0.78	0.26	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	61.77	16.30	6.01	8.58	0.00	0.00	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	104.17	7.62	13.97	8.89	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	43.50	9.34	9.61	4.00	0.00	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	86.51	14.67	9.58	5.39	0.00	0.30	1.20	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	64.84	7.20	6.64	2.54	0.00	0.14	0.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	57.97	13.06	9.24	6.05	0.00	1.27	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	76.29	23.66	8.40	9.51	0.22	0.00	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	85.32	12.89	16.68	6.45	0.00	0.00	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	47.45	10.80	10.23	2.84	0.00	0.28	1.42	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	82.84	14.01	9.09	6.39	0.25	0.74	0.49	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	95.14	15.64	9.78	2.61	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	69.68	9.11	10.29	2.35	0.29	0.88	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	97.45	15.28	9.51	7.78	0.00	1.73	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	119.93	3.71	7.42	3.30	0.00	0.00	0.41	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	72.06	7.15	8.64	3.57	0.30	0.60	0.60	0.30	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	42.77	1.78	1.78	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	66.70	0.66	2.63	0.66	0.00	0.66	0.00	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	36.82	2.10	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	71.96	4.74	9.49	2.37	0.00	0.20	0.79	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	71.71	3.73	4.66	0.00	0.00	1.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	65.72	0.75	2.25	0.75	0.38	0.38	0.00	0.38	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	63.39	6.13	7.19	3.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	64.69	2.15	3.17	0.79	0.00	0.11	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	85.46	5.16	4.42	2.21	0.00	0.74	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	57.16	1.10	2.20	0.73	0.00	0.00	0.73	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	7.78	9.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	69.48	1.07	1.60	1.07	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	11.59	0.00	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	81.81	3.03	9.09	2.02	0.00	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	47.65	2.53	1.26	0.00	0.00	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	230.17	4.09	0.00	1.36	1.36	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	60.40	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	20.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	117.81	6.04	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	3694.48	34.26	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	1696.47	19.57	9.79	0.00	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	1235.64	19.01	9.50	4.75	4.75	0.00	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	2108.24	12.55	0.00	37.65	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	68.51	4.31	2.80	1.72	0.43	0.86	0.22	0.43	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	64.28	4.70	7.32	2.09	0.52	1.05	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	29.37	5.34	7.34	2.67	0.00	0.00	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	48.42	7.93	10.85	3.76	0.00	0.83	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	30.23	3.23	6.65	2.09	0.00	0.00	0.00	0.00	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	89.37	3.19	6.38	3.19	0.00	0.00	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	29.92	4.76	8.16	5.44	0.00	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	3.68	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	80.36	16.74	14.65	7.12	0.00	0.00	0.84	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	64.85	11.62	12.09	9.30	0.00	0.23	0.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	66.75	13.51	12.43	5.13	0.27	0.54	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	72.95	7.15	9.88	2.94	0.63	0.84	0.42	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	45.66	7.45	9.43	1.99	0.00	0.50	0.99	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	108.00	7.31	11.37	1.89	0.27	0.54	0.27	0.00	0.27	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	100.42	19.72	8.39	7.71	0.23	0.68	0.68	0.91	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	81.81	13.39	14.70	4.57	0.16	0.16	0.16	0.65	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	79.83	6.38	5.83	2.37	0.36	0.55	0.00	0.55	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	79.57	12.73	6.37	3.71	1.06	1.59	1.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	153.68	12.61	13.81	5.40	0.00	0.60	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	98.78	4.59	9.19	5.91	0.33	0.33	0.66	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	126.20	24.39	10.90	10.08	0.33	0.81	1.30	0.49	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	116.06	9.35	8.29	4.94	0.35	0.53	0.53	0.00	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	119.55	22.50	7.74	5.63	2.11	0.70	1.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	147.57	13.33	11.95	4.60	0.46	0.46	0.46	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	150.71	10.93	9.64	6.43	0.00	0.96	0.64	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	118.30	13.80	10.35	6.90	0.69	1.38	1.72	0.34	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	2.53	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	106.27	7.13	8.47	4.23	0.45	0.45	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	123.21	16.51	10.58	4.66	0.42	0.42	0.85	0.85	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	129.12	10.21	13.29	5.46	0.24	0.24	0.47	0.47	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	125.34	7.73	12.02	6.01	0.86	0.00	0.43	0.43	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	9.03	9.03	9.03	0.00	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	112.63	9.00	11.00	3.00	0.67	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	95.58	10.37	8.57	7.21	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	88.88	9.52	8.33	5.16	0.40	0.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	96.58	18.57	8.36	7.43	0.00	1.86	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	146.05	6.05	7.19	3.78	0.38	0.00	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	86.03	15.32	9.45	4.24	0.00	0.65	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	119.84	7.84	13.51	4.36	0.00	0.00	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	82.77	7.24	5.43	4.98	0.00	0.00	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	82.02	11.46	6.17	4.41	0.00	0.00	0.00	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	99.73	9.97	12.63	7.31	0.00	0.66	0.66	1.33	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	167.17	9.42	10.42	6.45	0.00	1.49	0.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	107.19	12.63	7.66	4.98	0.00	1.53	1.15	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	82.87	4.54	6.35	1.81	0.00	0.30	0.00	0.30	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	81.78	7.29	3.98	2.43	0.22	0.00	0.22	0.00	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	115.20	12.88	4.74	1.36	0.68	0.00	1.36	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	5.11	0.00	5.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	164.00	12.80	6.71	4.27	0.00	1.83	1.22	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	111.73	8.18	7.55	1.57	0.00	0.31	0.00	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	111.68	8.78	11.80	4.54	0.30	0.61	0.91	0.91	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	117.09	7.12	5.54	5.54	0.79	0.79	2.37	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	105.43	9.07	5.67	2.27	0.00	2.27	2.27	0.00	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	5.06	0.00	0.00	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	18.51	2.24	1.12	1.12	0.12	0.37	0.12	0.12	0.00	0.00
Myoblast, donor2	11322-117D8	50.82	2.88	4.03	4.41	0.19	0.19	0.00	0.96	0.00	0.00
Myoblast, donor3	11398-118D3	25.06	0.67	1.51	0.17	0.00	0.00	0.34	0.00	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	131.19	4.67	4.52	1.90	0.29	1.02	0.44	0.44	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	2010.24	54.12	32.60	12.30	15.68	8.92	11.69	9.53	2.46	2.77
Natural Killer Cells, donor2	11311-117C6	1971.27	45.84	24.73	9.95	9.65	19.90	10.55	12.06	2.11	2.11
Natural Killer Cells, donor3	11387-118C1	2108.15	58.35	35.52	16.75	11.04	13.62	10.12	11.04	1.84	2.76
Neural stem cells, donor1	11275-116H6	154.25	1.45	1.81	0.36	0.73	0.36	0.36	0.73	0.36	0.00
Neural stem cells, donor2	11352-117H2	261.89	0.00	5.78	1.93	1.93	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	137.69	1.14	1.14	0.00	0.00	1.14	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	187.14	0.44	1.32	0.44	0.00	0.44	0.88	0.22	0.00	0.00
Neurons, donor3	11655-122E8	157.03	0.82	3.29	0.00	1.64	2.47	0.82	1.64	0.82	0.00
Neutrophils, donor1	11233-116C9	666.31	33.41	63.10	8.35	6.50	1.86	1.86	2.78	0.00	0.00
Neutrophils, donor2	11314-117C9	373.96	14.49	31.89	5.80	0.00	5.80	2.90	8.70	2.90	2.90
Neutrophils, donor3	11390-118C4	713.46	27.49	43.37	9.77	1.83	3.67	3.05	1.22	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	198.88	6.65	5.82	2.85	0.24	0.83	0.47	0.83	0.36	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	89.87	5.21	2.60	3.26	0.33	0.65	0.33	1.30	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	81.22	3.21	5.01	2.01	0.00	0.20	0.40	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	107.51	5.37	6.88	2.62	0.28	0.55	0.69	0.28	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	141.56	6.95	6.80	2.61	0.43	1.74	0.87	0.29	0.14	0.14
Olfactory epithelial cells, donor3	11935-125I9	126.33	7.38	5.79	2.50	0.68	1.36	0.45	0.79	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	96.91	6.33	7.30	2.43	0.29	0.49	0.10	0.39	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	186.56	6.02	2.41	1.20	0.60	1.20	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	102.73	7.02	5.96	1.28	0.85	1.28	0.64	0.43	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	229.77	14.86	9.14	6.86	10.29	3.43	11.43	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	201.73	16.14	9.93	4.34	4.34	3.10	0.00	0.62	0.00	0.62
Osteoblast, donor1	11277-116H8	185.08	7.43	8.01	3.52	0.59	0.98	0.59	0.98	0.20	0.00
Osteoblast, donor2	11354-117H4	97.62	5.62	5.62	0.70	0.00	0.70	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	118.90	5.69	7.64	3.02	0.18	0.36	0.53	0.53	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	82.21	6.23	5.14	3.03	1.01	0.84	0.59	0.17	0.17	0.25
Pericytes, donor1	11491-119E6	181.25	5.67	7.90	2.34	0.56	0.78	0.56	0.67	0.22	0.00
Pericytes, donor2	11571-120E5	116.80	3.62	4.75	1.81	0.45	0.91	0.91	0.68	0.00	0.23
Pericytes, donor3	11652-122E5	87.08	5.09	5.70	2.03	0.61	0.61	0.81	0.61	0.41	0.00
Perineurial Cells, donor1	11499-119F5	67.93	1.70	2.71	0.34	0.00	0.11	0.34	0.11	0.00	0.00
Perineurial Cells, donor2	11579-120F4	68.73	4.97	3.77	2.76	0.18	0.18	0.18	0.37	0.00	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	891.20	21.36	20.08	6.69	4.46	4.46	2.23	2.87	0.32	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	863.63	30.36	23.51	9.55	3.43	10.77	4.90	5.14	0.98	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	720.07	16.69	20.45	7.12	4.53	7.38	4.66	2.85	0.52	1.16
Placental Epithelial Cells, donor1	11278-116H9	202.57	5.26	5.50	1.91	0.48	0.72	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	192.95	3.33	2.22	0.00	0.00	0.00	2.22	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	161.18	2.16	3.34	1.18	0.79	0.39	0.00	0.79	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	54.75	5.38	5.38	2.22	0.00	0.95	0.32	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	92.29	4.88	4.13	2.25	0.56	0.38	0.94	0.38	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	29.37	3.52	1.96	0.26	0.00	0.13	0.39	0.00	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	65.74	3.38	6.53	2.93	0.00	2.03	0.68	0.68	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	134.58	5.01	3.41	3.09	0.96	1.07	1.07	0.53	0.11	0.32
Preadipocyte - omental, donor2	11329-117E6	75.07	2.18	1.31	1.31	0.44	0.44	0.87	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	105.14	8.31	7.88	3.15	0.29	1.29	1.29	1.00	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	123.03	4.92	5.91	2.95	0.00	0.00	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	72.17	4.30	3.99	2.46	0.61	0.31	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	39.84	4.25	4.96	1.42	0.18	0.71	0.00	0.00	0.18	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	63.86	3.75	5.96	1.02	0.51	0.51	0.34	0.17	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	53.84	4.75	4.84	2.42	0.19	0.47	0.19	0.19	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	52.92	3.22	6.44	0.92	0.46	0.46	0.00	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	37.62	2.09	3.66	1.04	0.21	0.10	0.00	0.10	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	157.64	2.72	1.81	0.45	2.56	1.66	0.75	1.81	0.15	0.15
Prostate Epithelial Cells, donor2	11331-117E8	33.85	2.17	2.84	1.08	0.14	0.27	0.27	0.14	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	66.75	1.78	1.41	0.43	0.61	0.49	0.24	0.12	0.00	0.24
Prostate Stromal Cells, donor1	11254-116F3	72.21	4.44	3.42	1.25	0.34	0.34	0.68	0.46	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	88.04	8.25	8.43	4.66	0.90	0.90	0.36	0.18	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	84.98	6.88	6.57	3.75	0.94	0.94	0.31	0.83	0.63	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	149.64	12.41	6.57	2.55	0.00	0.36	1.82	1.46	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	122.82	4.99	2.36	1.73	0.07	0.62	0.21	0.35	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	272.89	6.59	7.61	5.07	0.00	2.54	0.51	1.01	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	122.35	6.40	7.11	2.13	0.00	0.00	0.71	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	112.32	5.82	3.60	2.01	0.42	0.11	0.21	0.42	0.00	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	82.38	1.36	0.68	1.36	0.68	0.00	1.36	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	59.30	1.89	2.83	0.54	0.13	0.00	0.13	0.40	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	61.50	1.55	3.11	0.67	0.00	0.44	0.44	0.00	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	127.10	2.66	7.32	2.00	0.00	2.00	2.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	172.99	6.60	6.60	3.52	0.22	0.44	0.88	0.66	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	138.56	5.64	15.05	1.88	1.88	0.63	1.25	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	204.73	13.04	8.88	3.88	1.11	1.39	0.83	1.66	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	99.32	2.42	2.95	3.22	0.00	0.27	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	89.40	6.33	3.37	0.42	0.42	1.69	0.42	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	127.09	4.05	5.21	2.31	0.39	0.58	0.96	0.39	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	297.91	9.07	3.11	3.11	0.26	1.56	0.26	0.00	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	249.00	6.82	5.12	2.84	0.28	1.99	1.99	0.85	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	184.21	5.15	2.06	5.15	1.03	1.03	0.00	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	204.74	6.02	4.27	1.25	0.25	1.51	0.50	0.50	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	341.04	7.48	6.95	3.07	1.20	2.54	0.94	2.54	0.13	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	57.18	15.19	8.93	5.36	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	11.56	2.75	4.95	1.65	0.55	0.00	0.00	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	34.22	4.64	6.38	0.58	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	49.41	3.38	5.07	1.04	0.39	0.00	0.13	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	48.86	3.87	5.86	2.78	0.10	0.70	0.10	0.10	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	59.90	4.91	6.36	2.34	0.11	0.33	0.22	0.11	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	52.59	2.36	6.57	2.23	0.00	0.37	0.50	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	56.87	3.85	7.34	2.56	0.23	0.47	0.47	0.12	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	64.25	4.16	10.40	2.77	0.00	0.00	0.00	0.46	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	48.60	3.56	7.94	1.51	0.00	0.00	0.00	0.27	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	53.55	2.57	6.05	2.72	0.00	0.45	0.30	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	61.28	4.66	6.09	1.79	0.00	0.00	0.18	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	52.51	3.16	8.03	1.72	0.00	0.14	0.43	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	56.55	4.72	6.98	2.15	0.11	0.32	0.11	0.11	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	58.19	3.76	4.65	2.88	0.00	0.00	0.00	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	39.57	4.97	11.09	1.34	0.00	0.38	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	51.80	3.91	7.73	2.42	0.09	0.56	0.00	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	58.81	4.89	5.45	2.07	0.19	0.19	0.38	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	52.29	4.64	8.10	2.65	0.00	0.13	0.40	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	61.03	3.89	8.37	2.82	0.10	0.19	0.29	0.19	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	67.22	4.01	7.64	2.10	0.00	0.19	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	61.41	5.23	8.33	1.71	0.00	0.11	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	60.83	4.48	10.65	2.24	0.28	0.00	0.84	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	59.81	4.61	8.37	2.05	0.00	0.00	0.17	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	49.59	4.01	6.02	2.73	0.00	0.00	0.00	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	68.55	5.76	8.58	2.45	0.12	0.37	0.25	0.37	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	72.67	5.78	7.66	2.69	0.00	0.81	0.13	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	55.67	6.60	12.74	1.65	0.00	0.00	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	74.80	4.76	9.33	2.38	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	67.58	6.78	8.18	3.04	0.00	0.23	0.94	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	44.79	2.28	8.50	3.73	0.21	0.62	0.21	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	68.35	5.75	4.65	2.88	0.00	0.88	0.44	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	53.06	4.18	10.86	3.55	0.00	0.21	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	46.03	4.85	9.42	1.48	0.00	0.13	0.40	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	49.90	4.09	7.83	2.72	0.17	0.34	0.00	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	51.67	6.56	5.40	2.70	0.19	0.00	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	36.45	1.89	6.71	1.38	0.00	0.52	0.17	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	39.50	3.02	6.04	2.47	0.14	0.41	0.00	0.27	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	46.62	3.61	6.73	3.12	0.00	0.49	0.00	0.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	38.52	4.60	7.67	2.05	0.17	0.17	0.17	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	62.59	5.33	8.58	2.96	0.00	0.59	0.15	0.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	35.18	7.20	9.06	1.07	0.00	0.27	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	56.41	4.01	10.37	1.52	0.28	0.00	0.14	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	61.67	5.00	11.19	2.62	0.24	0.71	0.00	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	49.18	8.06	13.70	5.04	0.20	0.20	0.00	0.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	51.70	6.31	11.11	2.07	0.09	0.09	0.38	0.09	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	64.98	8.38	14.32	4.54	0.00	0.70	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	43.52	7.56	8.76	4.23	0.00	0.00	0.91	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	64.86	4.41	13.58	2.81	0.24	0.00	0.37	0.49	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	67.97	7.71	6.26	3.35	0.00	0.29	0.00	0.15	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	61.45	8.52	9.73	3.04	0.00	0.00	0.61	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	55.76	8.74	12.06	3.32	0.30	0.00	0.00	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	74.19	10.40	13.35	7.69	0.23	0.68	0.00	0.68	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	67.70	7.19	8.69	3.29	0.00	0.90	0.60	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	78.17	6.02	8.27	2.13	0.83	0.12	0.12	0.47	0.12	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	87.51	9.82	14.51	4.70	1.49	0.43	1.71	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	83.54	11.42	9.62	3.00	1.20	0.60	1.80	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	110.40	4.14	3.01	1.32	0.38	0.38	0.94	0.56	0.19	0.19
Schwann Cells, donor2	11578-120F3	47.63	3.40	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	101.00	4.38	4.82	1.75	0.00	0.44	0.00	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	90.38	4.38	2.19	2.74	0.00	0.00	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	42.28	2.76	1.84	0.92	0.46	0.92	0.00	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	111.71	3.92	5.15	1.44	0.00	0.62	1.24	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	130.87	4.97	3.31	1.66	4.97	0.00	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	132.75	19.77	2.82	2.82	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	123.52	3.17	4.84	1.14	1.58	0.35	0.35	0.97	0.09	0.26
Skeletal Muscle Cells, donor2	11358-117H8	235.65	17.35	15.18	7.95	1.45	2.17	0.00	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	110.36	4.18	6.69	4.18	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	54.51	4.24	4.56	1.73	0.00	0.47	0.16	0.16	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	53.66	5.05	4.91	2.08	0.00	0.30	0.00	0.30	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	60.48	3.69	3.85	2.15	0.15	0.00	0.15	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	89.46	4.79	6.05	2.02	0.25	0.50	0.50	0.25	0.00	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	65.64	6.42	8.42	3.71	0.14	0.29	0.86	0.29	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	67.56	5.26	6.55	3.47	0.30	0.89	0.30	0.30	0.00	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	80.63	3.12	4.55	1.77	0.25	0.00	0.08	0.25	0.17	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	94.81	2.17	3.62	0.72	0.72	0.72	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	122.88	8.81	7.16	3.16	0.00	0.41	0.41	0.41	0.00	0.00
Skin - palm, donor1	10286-104F7	491.56	8.06	21.49	5.37	0.00	0.00	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	40.65	1.59	1.87	0.72	0.14	0.43	0.00	0.43	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	51.53	0.82	4.09	0.00	0.00	0.00	0.00	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	34.53	0.91	1.43	0.13	0.26	0.26	0.13	0.52	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	47.82	1.81	1.25	0.28	0.97	0.56	0.00	0.28	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	43.46	1.41	1.97	0.56	0.00	0.00	0.28	0.14	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	167.04	1.27	1.69	0.21	0.21	0.21	0.21	0.42	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	83.42	1.57	1.87	1.05	0.37	0.37	0.30	0.30	0.22	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	45.98	3.09	8.02	2.78	0.31	0.00	0.62	0.31	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.12	0.89	1.78	0.22	0.22	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	70.54	2.35	5.88	2.35	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	101.66	5.75	6.19	1.33	0.00	0.44	0.22	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	40.56	1.97	3.94	1.18	0.00	0.39	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	71.08	3.86	5.41	1.55	0.00	0.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	76.06	3.00	6.00	1.00	0.00	0.00	0.00	2.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	54.96	2.26	2.26	1.20	0.27	0.40	0.00	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	66.05	3.99	5.98	2.88	0.44	0.89	0.00	0.00	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	47.50	1.79	1.92	1.28	0.13	0.00	0.26	0.26	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	79.77	2.28	3.58	1.30	0.00	0.00	0.33	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	108.98	5.91	3.54	3.54	1.18	0.30	1.18	0.59	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	69.19	5.41	4.27	2.56	0.14	0.71	0.14	0.14	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	149.66	8.78	10.90	5.37	0.16	0.49	0.65	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	109.60	8.22	8.22	3.04	0.00	0.30	0.61	0.61	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	65.67	3.79	5.05	3.28	0.51	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	97.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	83.92	8.11	4.29	1.91	0.00	0.00	1.43	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	73.44	5.60	3.54	2.06	0.44	0.44	0.44	0.29	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	63.93	3.87	6.46	0.65	0.43	1.08	0.65	0.43	0.22	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	79.56	7.14	4.83	2.94	0.10	0.31	0.84	0.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	47.49	2.63	3.09	2.47	0.31	0.00	0.15	0.00	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	65.75	6.47	6.47	2.16	0.00	1.08	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	40.05	2.39	3.89	1.20	0.30	0.00	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	143.39	7.51	9.90	3.76	0.00	1.37	0.00	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	90.94	3.77	5.26	2.12	0.00	0.31	0.16	0.24	0.00	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	85.75	3.52	4.13	1.81	2.11	1.31	0.40	0.70	0.00	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	61.89	5.23	4.10	1.82	0.23	0.00	0.00	0.68	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	79.10	5.43	9.06	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	51.66	1.32	3.71	0.79	0.00	0.26	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	102.67	4.26	4.93	2.53	0.67	0.27	0.00	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	65.11	4.51	5.51	1.75	0.50	0.50	0.50	0.38	0.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	142.30	13.19	10.40	5.58	0.51	0.51	1.01	0.76	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	56.09	3.32	5.13	0.75	0.15	0.15	0.00	0.00	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	83.27	3.75	5.25	3.75	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	439.35	6.46	27.14	1.29	0.00	0.00	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	76.27	5.12	3.72	2.33	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	77.75	5.05	1.01	1.51	0.50	0.00	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	72.08	4.39	4.70	1.25	0.31	0.63	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	81.42	11.21	4.13	4.13	0.29	0.29	0.59	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	48.40	3.67	4.08	2.25	0.00	0.08	0.08	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	115.39	14.95	9.81	7.01	1.40	0.47	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	62.32	4.17	3.60	1.44	0.29	0.14	0.29	0.29	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	79.80	4.33	5.86	2.55	0.76	0.76	0.51	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	60.36	4.32	2.26	1.13	0.38	0.00	0.19	0.19	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	116.13	5.87	3.49	2.52	0.28	0.98	0.14	0.28	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	120.65	4.94	3.69	2.18	0.08	0.25	0.25	0.08	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	113.33	8.57	14.76	3.81	0.48	0.48	0.48	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	68.51	2.69	2.94	2.45	0.73	0.49	0.73	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	65.18	2.87	2.65	2.21	0.44	0.22	0.00	0.88	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	137.22	9.95	7.31	5.27	0.00	1.76	0.59	0.88	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	87.27	7.97	8.55	2.92	0.58	0.19	0.39	0.58	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	59.24	3.97	5.55	1.85	0.00	0.00	0.26	0.00	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	17.11	1.49	3.35	0.37	0.37	2.60	0.00	1.12	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	49.95	5.03	4.31	2.16	1.08	0.36	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	41.17	1.99	2.56	0.85	0.28	0.57	0.85	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	53.17	1.58	7.48	1.58	0.00	0.79	0.39	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	44.19	2.79	4.06	1.02	0.51	0.00	0.25	0.00	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	87.05	7.19	7.99	0.40	1.20	0.40	0.40	0.40	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	139.61	11.70	6.27	3.76	1.67	0.84	0.42	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	137.51	12.38	9.17	2.29	0.46	0.46	1.38	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	190.37	11.61	2.86	4.38	0.34	0.84	0.17	0.34	0.17	0.00
Synoviocyte, donor2	11368-117I9	164.27	9.22	4.53	4.69	2.51	1.01	1.01	1.17	0.17	0.17
Synoviocyte, donor3	11440-118H9	112.38	9.38	4.69	2.46	0.22	0.89	0.00	0.67	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	107.20	6.79	7.15	2.50	0.36	0.00	0.36	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	63.43	5.95	3.96	0.00	0.00	1.98	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	110.22	4.40	8.80	3.01	0.00	0.69	0.46	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	51.83	1.43	1.79	0.79	0.14	0.43	0.50	0.29	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	51.03	0.00	4.25	0.39	0.00	0.39	0.00	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	87.62	4.01	4.01	0.57	0.57	0.57	0.00	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	342.01	9.60	5.66	2.95	2.46	2.09	0.86	1.97	0.12	0.12
Urethra, donor2	10319-105A4	262.57	17.98	8.99	5.40	1.80	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	51.54	3.98	3.72	0.80	0.00	0.00	0.27	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	38.45	2.80	3.61	0.80	0.00	0.40	0.80	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	55.01	3.90	4.13	1.15	0.23	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	73.11	3.12	5.13	1.34	0.22	0.45	0.22	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	403.07	10.68	24.02	3.56	0.00	1.78	1.78	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	501.79	11.44	14.30	4.29	0.00	0.00	1.43	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	253.27	12.32	18.48	5.48	0.68	0.68	0.00	0.68	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	216.59	7.58	14.81	2.75	0.00	1.72	0.69	1.03	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	259.72	8.72	16.27	1.74	0.00	0.00	1.74	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	427.95	8.33	23.95	5.21	0.00	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	411.17	10.10	13.77	1.84	0.00	0.92	0.92	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	260.18	10.04	10.04	6.39	0.00	1.83	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	222.05	8.64	3.82	2.96	0.49	0.99	1.11	0.62	0.25	0.12
Wilms' tumor cell line:HFWT	10597-108E3	171.61	4.40	3.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	86.31	3.07	3.07	0.84	0.00	0.56	0.28	0.56	0.00	0.28
achilles tendon, donor2	10292-104G4	357.51	2.07	6.20	0.00	0.00	4.13	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	135.13	1.27	1.27	1.02	0.00	0.51	1.78	0.51	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	96.12	1.39	4.18	0.46	0.23	0.23	0.23	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	234.45	4.75	5.10	2.85	0.12	1.19	1.66	1.42	0.24	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	72.65	1.09	1.90	0.82	0.00	0.54	0.54	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	47.78	0.56	6.46	0.00	0.00	0.00	1.12	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	290.58	7.40	12.69	4.86	0.42	1.06	0.63	0.63	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	138.28	9.53	14.43	6.26	0.00	0.00	1.09	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	126.02	1.76	5.73	1.76	0.00	0.44	1.76	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	129.86	2.04	2.45	1.63	0.00	0.00	0.82	0.82	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	182.89	10.10	10.48	3.88	0.39	0.39	0.39	0.39	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	19.69	0.18	3.13	0.55	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	436.86	11.70	0.00	15.60	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	168.24	7.44	7.44	4.42	0.00	1.16	0.93	0.46	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	376.18	20.45	13.20	8.03	0.26	2.85	2.85	1.04	0.26	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	121.57	10.81	13.15	4.97	0.00	0.88	0.88	0.88	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	71.11	4.18	5.11	1.86	0.00	0.93	0.93	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	87.19	4.94	7.40	2.06	0.00	0.00	0.41	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	46.04	5.22	17.80	1.53	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	49.50	2.99	5.55	1.28	0.00	0.00	0.43	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	42.76	2.43	4.25	0.00	0.00	0.30	0.00	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	110.00	4.57	5.05	1.93	0.00	0.00	0.96	0.48	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	12.03	0.22	1.78	0.00	0.00	0.22	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	161.10	14.34	3.67	8.01	0.33	0.33	2.00	0.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	172.81	7.43	9.29	1.86	0.00	0.00	1.86	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	152.17	3.01	4.90	1.13	0.38	0.75	0.00	0.75	1.88	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	101.62	7.41	7.41	2.18	0.00	0.00	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	245.55	16.87	5.62	11.25	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	113.04	16.25	10.83	4.71	0.24	0.00	0.71	0.47	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	280.77	7.76	10.39	1.24	2.64	0.93	1.09	1.24	0.00	0.47
adipose, donor1	10184-103D4	138.98	0.59	1.76	0.59	1.76	1.76	1.76	1.17	0.00	0.59
adipose, donor2	10185-103D5	526.77	2.84	5.27	1.62	4.06	0.41	2.43	2.84	0.81	0.00
adipose, donor3	10186-103D6	323.21	1.36	3.54	0.00	3.27	1.09	1.09	0.54	0.82	0.54
adipose, donor4	10187-103D7	139.55	0.87	0.87	0.87	2.60	2.60	1.73	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	84.28	6.47	6.79	3.16	0.32	0.00	0.47	0.16	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	287.38	10.91	3.64	0.00	0.00	3.64	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	249.47	12.14	8.27	4.40	1.33	1.87	4.00	1.33	0.40	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	57.53	4.64	6.43	1.43	0.36	0.36	0.00	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	523.05	6.96	3.94	2.09	1.16	2.09	1.39	0.70	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	298.21	7.44	4.06	1.69	1.35	0.68	2.03	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	323.47	5.89	5.60	1.47	0.29	0.59	0.88	0.59	0.00	0.00
amygdala - adult, donor10196	10167-103B5	135.18	8.30	8.30	1.19	1.19	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	220.61	4.06	4.06	1.62	0.00	0.81	0.41	0.41	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	113.94	3.23	4.20	1.61	0.65	0.00	0.32	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	138.66	13.37	11.97	3.44	1.02	1.27	0.76	0.89	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	142.08	3.09	1.99	0.66	0.22	0.22	0.44	0.22	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	209.44	2.00	1.00	0.00	0.00	0.67	0.00	1.00	0.33	0.00
aorta, adult, pool1	10052-101G7	389.13	17.06	10.79	4.51	0.78	0.98	1.18	1.57	0.39	0.20
appendix, adult	10189-103D9	373.37	12.42	8.54	3.49	2.72	1.94	1.94	0.78	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	133.10	4.82	6.88	1.03	0.34	0.34	0.34	0.34	0.34	0.00
artery, adult	10190-103E1	241.85	6.79	2.72	2.72	4.08	1.36	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	114.88	2.46	2.17	1.01	0.14	0.72	0.72	0.00	0.14	0.14
b cell line:RPMI1788	10427-106D4	153.61	4.46	5.95	1.04	0.59	0.74	0.59	0.30	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	83.23	6.94	4.72	1.39	0.28	0.55	1.11	0.55	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	56.17	1.89	1.59	0.69	0.30	0.00	0.20	0.10	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	30.13	1.00	2.34	1.00	0.00	0.00	0.00	0.33	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	286.89	8.95	17.34	1.68	0.56	2.24	2.80	1.12	0.56	0.56
bladder, adult, pool1	10011-101C2	272.58	17.06	13.15	3.69	1.74	1.20	0.87	1.52	0.00	0.11
blood, adult, pool1	10053-101G8	409.71	15.50	22.15	6.64	0.00	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	121.60	5.14	10.28	1.71	0.86	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	106.62	3.37	3.37	1.35	0.67	0.67	1.35	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	228.59	7.18	6.15	3.08	3.08	0.00	0.00	2.05	1.03	0.00
brain, adult, pool1	10012-101C3	307.24	7.80	7.24	2.45	0.56	2.34	0.45	0.56	0.56	0.33
brain, fetal, pool1	10085-102B4	307.21	0.00	5.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	310.54	11.56	6.61	5.29	0.00	0.99	3.30	0.66	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	297.58	3.00	2.12	0.87	0.75	1.25	0.87	0.25	0.00	0.00
breast, adult, donor1	10080-102A8	270.85	12.00	18.31	3.16	1.89	3.16	0.63	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	35.95	0.38	2.29	1.65	0.00	0.13	0.13	0.25	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	100.19	3.40	4.95	2.78	0.00	0.31	0.31	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	26.01	7.83	9.90	4.37	0.23	0.92	0.69	0.23	0.00	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	76.26	6.78	5.33	3.63	0.00	0.48	0.24	0.00	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	165.97	1.88	4.70	0.47	1.41	1.41	0.94	0.94	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	216.57	2.84	2.19	1.53	0.22	0.88	1.09	0.22	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	179.05	3.80	8.56	1.58	0.00	2.22	0.95	0.95	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	91.83	2.66	10.11	2.66	0.27	0.27	0.00	0.00	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	186.51	4.61	2.30	2.30	0.00	1.15	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	174.19	2.01	2.51	0.67	0.00	0.67	0.50	1.00	0.17	0.00
caudate nucleus, adult, donor10258	10379-105H1	204.03	0.76	4.58	1.53	1.53	1.53	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	111.33	4.39	0.73	1.83	0.00	0.00	0.00	0.37	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	250.54	0.00	0.00	2.91	0.00	2.91	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	330.94	1.49	1.07	0.21	0.00	1.28	0.85	0.64	0.43	0.00
cerebellum, adult, pool1	10083-102B2	233.87	0.69	1.38	0.00	1.03	0.34	0.69	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	134.51	2.49	1.66	0.00	0.83	0.00	0.00	0.00	0.00	1.66
cerebral meninges, adult	10188-103D8	381.23	9.08	10.59	4.03	1.01	0.76	1.01	0.50	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	137.41	3.65	8.04	0.73	0.00	1.46	2.19	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	358.31	4.17	4.17	1.29	1.73	0.72	1.15	0.29	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	195.88	3.48	1.66	0.50	0.66	0.99	0.66	0.33	0.00	0.00
cervix, adult, pool1	10013-101C4	378.70	11.97	12.07	4.30	5.25	1.89	1.36	0.94	0.10	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	155.92	9.06	7.11	3.20	0.00	0.70	0.70	0.70	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	182.88	3.92	10.45	5.23	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	273.53	7.33	12.05	4.35	3.23	1.12	1.62	1.99	0.12	1.37
choriocarcinoma cell line:SCH	10785-110H2	106.70	4.19	5.42	2.46	0.37	0.62	0.62	0.37	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	85.15	4.03	6.17	1.66	0.00	0.47	0.24	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	996.08	11.68	6.55	4.56	0.57	4.56	3.70	1.42	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	231.97	8.05	4.57	2.49	1.49	1.09	1.19	0.60	0.20	0.50
chorionic membrane cells, donor3	12240-129G8	764.88	7.69	4.40	2.20	1.65	2.20	3.85	1.10	1.10	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	113.10	6.06	3.03	2.02	0.00	1.01	1.01	0.00	2.02	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	126.21	7.11	8.07	3.84	0.38	0.38	0.38	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	195.77	10.98	8.45	4.01	0.21	0.84	0.42	0.00	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	116.59	4.37	5.14	1.54	0.00	1.28	0.26	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	134.00	7.01	5.08	2.42	0.73	0.97	0.24	0.24	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	116.26	7.33	4.28	2.44	0.00	1.83	0.61	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	91.87	3.83	2.65	1.77	0.00	0.59	0.29	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	368.00	9.64	4.69	2.61	0.26	1.04	1.04	0.78	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	37.94	3.20	5.49	0.46	0.00	0.23	0.23	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	286.29	17.52	10.24	7.46	1.04	3.64	1.39	1.39	0.69	0.00
colon carcinoma cell line:CACO-2	10513-107D9	89.51	2.38	1.28	0.37	0.18	1.46	0.00	0.18	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	168.00	2.28	5.70	0.38	0.38	0.38	0.38	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	190.41	15.47	11.90	2.38	0.00	1.19	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	402.45	15.16	12.46	5.52	7.52	1.76	0.82	1.06	0.12	0.47
colon, fetal, donor1	10070-101I7	328.77	28.43	11.74	11.74	1.24	2.47	1.24	1.24	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	4611.02	59.59	50.42	18.33	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	976.43	0.00	25.04	0.00	0.00	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	634.85	74.36	6.37	20.82	1.27	2.12	3.82	1.70	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	323.30	31.85	6.34	11.47	5.58	2.41	1.06	1.81	0.45	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	324.04	38.36	6.06	16.08	0.85	1.97	2.26	2.12	0.28	0.00
corpus callosum, adult, pool1	10042-101F6	461.82	8.07	4.98	4.20	0.33	1.88	1.00	0.77	0.11	0.22
cruciate ligament, donor2	10295-104G7	327.43	5.67	9.73	1.62	0.00	0.00	0.00	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	284.11	4.82	4.82	2.41	0.00	0.80	0.80	0.80	0.00	0.00
diencephalon, adult	10193-103E4	119.03	4.56	1.92	0.48	0.48	1.20	0.24	0.24	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	99.19	0.69	4.82	0.92	0.23	0.23	0.46	0.23	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	119.76	2.05	2.05	0.51	0.26	0.77	0.51	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	108.32	4.57	2.89	1.93	0.48	0.24	1.44	0.72	0.24	0.24
ductus deferens, adult	10196-103E7	165.45	7.97	5.98	4.49	0.00	1.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	285.17	12.96	10.08	5.76	1.44	1.44	2.88	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	192.00	13.98	8.09	1.47	0.74	1.47	6.62	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	324.98	3.22	3.47	1.24	1.57	0.66	0.66	1.16	0.17	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	492.56	4.66	1.55	1.78	7.11	1.55	1.78	2.44	0.44	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	56.89	0.72	1.72	0.14	0.14	0.43	0.57	0.29	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	108.52	3.08	6.78	1.85	0.00	0.00	1.23	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	85.67	3.33	2.12	0.91	0.00	0.91	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	82.44	1.85	1.54	0.62	0.00	0.00	0.31	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	86.69	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	82.12	2.68	4.02	1.01	0.67	1.01	0.34	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	131.40	2.54	4.89	0.72	0.18	0.54	0.72	0.72	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	85.55	0.48	1.93	0.64	0.16	0.80	1.13	0.32	0.00	0.32
epidermoid carcinoma cell line:A431	10426-106D3	79.48	3.00	1.45	0.78	0.22	0.33	0.22	0.22	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	109.44	3.74	2.97	1.32	0.11	0.55	0.77	0.22	0.11	0.00
epididymis, adult	10197-103E8	240.71	9.84	9.00	2.09	1.88	0.84	0.63	0.21	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	266.29	4.79	4.26	1.60	0.18	1.06	1.06	0.35	0.00	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	32.64	1.97	2.36	1.18	0.00	0.39	0.00	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	83.22	5.77	4.19	1.97	0.26	0.79	0.92	0.13	0.26	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	95.57	5.22	4.82	2.36	0.30	0.59	0.20	0.49	0.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	74.84	5.49	2.91	1.79	0.34	0.56	0.45	0.45	0.00	0.00
esophagus, adult, pool1	10015-101C6	205.03	13.06	6.69	3.29	1.81	1.38	0.85	0.85	0.32	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	584.85	26.68	6.89	14.53	1.88	2.63	1.50	1.25	0.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	178.68	7.24	12.07	0.00	0.00	0.00	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	159.92	8.42	6.31	0.00	0.00	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	211.33	5.95	8.93	1.49	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	182.29	4.59	3.44	2.29	0.00	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	441.59	10.20	7.29	0.00	0.00	2.91	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	231.10	8.90	8.39	1.53	0.25	1.53	0.51	0.00	0.76	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	41.54	1.67	6.92	0.51	0.51	0.13	0.26	0.13	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	43.92	8.07	7.36	3.32	0.00	0.24	0.47	0.24	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	330.92	7.60	8.44	2.72	0.47	1.03	0.56	0.56	0.09	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	182.85	9.01	4.50	3.30	1.50	0.90	1.80	0.30	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	39.04	7.04	5.67	3.29	0.00	0.09	0.18	0.09	0.09	0.00
gall bladder, adult	10198-103E9	315.79	13.04	10.86	4.59	1.93	0.48	0.97	0.97	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	221.72	9.13	24.70	3.76	0.54	0.54	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	221.11	13.07	15.31	4.86	2.24	1.12	0.75	1.12	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	253.46	5.28	2.11	2.32	0.63	1.90	1.69	0.21	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	139.07	7.54	6.77	2.13	0.00	0.39	0.77	1.16	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	131.00	4.43	3.12	1.15	0.00	0.82	0.98	0.00	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	86.03	6.41	12.81	2.75	0.92	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	363.93	17.82	5.71	5.48	1.37	2.28	1.83	1.83	0.23	0.91
giant cell carcinoma cell line:LU65	10487-107B1	45.44	0.34	0.80	0.34	0.34	0.00	0.11	0.23	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	127.22	9.52	13.58	4.62	0.70	0.14	1.26	0.42	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	72.83	3.24	2.00	0.25	0.00	0.50	1.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	79.80	2.43	3.38	0.95	0.00	0.11	0.42	0.11	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	93.53	2.53	3.37	0.28	0.00	0.28	0.70	0.00	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	71.08	3.86	3.97	1.21	0.00	0.33	0.33	0.22	0.00	0.00
glioma cell line:GI-1	10413-106B8	93.14	3.22	6.74	1.46	0.59	0.59	0.29	0.29	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	209.93	1.46	0.73	2.19	0.00	2.92	2.19	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	192.35	5.86	1.71	1.95	0.24	0.49	0.00	0.24	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	261.52	8.22	8.22	2.74	0.00	0.00	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	119.91	3.73	1.60	3.20	0.53	0.53	0.00	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	3528.78	51.39	61.18	24.47	0.00	0.00	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	622.92	10.93	0.00	0.00	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	360.63	5.23	15.68	0.00	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	121.92	2.88	9.60	1.60	0.00	0.32	0.64	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	74.38	2.30	5.51	0.92	0.00	0.46	1.38	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	58.53	1.37	2.29	0.00	0.46	0.46	0.46	0.46	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	70.21	1.29	2.58	0.64	0.00	0.64	1.29	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	18.68	1.44	7.19	0.00	0.00	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	46.64	1.37	2.74	0.69	0.00	0.00	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	105.93	0.00	6.62	0.00	0.00	0.00	0.00	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	674.40	35.34	7.47	12.93	0.86	4.02	2.59	2.59	0.57	0.00
heart - mitral valve, adult	10205-103F7	296.87	7.47	3.89	2.99	0.60	2.09	2.09	2.09	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	178.06	9.41	6.01	3.14	0.26	0.52	0.78	0.78	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	262.28	3.33	5.00	1.67	0.00	0.00	0.83	0.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	136.72	3.47	3.47	1.43	0.20	0.61	0.41	0.41	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	213.77	5.54	1.70	1.70	0.00	4.26	0.85	1.28	0.00	0.00
heart, adult, pool1	10016-101C7	227.68	4.14	3.68	1.84	0.23	0.00	0.46	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	247.77	6.88	4.93	1.54	0.31	0.62	0.51	0.92	0.00	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	81.14	8.64	8.64	4.94	0.00	0.62	0.31	0.62	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	298.48	10.70	5.95	5.95	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	111.60	3.09	2.21	0.99	0.11	0.44	0.66	0.44	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	116.52	3.16	3.16	1.82	0.49	0.49	0.12	0.61	0.36	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	121.06	3.03	3.64	0.81	0.20	0.20	0.51	0.51	0.20	0.20
hepatoma cell line:Li-7	10484-107A7	134.68	2.56	1.45	0.11	0.67	0.67	1.00	0.33	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	51.26	1.11	1.71	0.50	0.00	0.30	0.40	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	128.70	4.73	0.00	0.95	0.95	0.95	0.95	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	195.12	2.65	3.67	0.61	0.82	0.61	0.82	1.22	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	140.42	2.99	8.96	1.00	0.00	0.50	1.49	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	95.52	4.58	2.47	2.11	1.06	0.35	0.35	0.35	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	120.24	3.05	1.83	0.61	1.22	2.44	0.61	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	131.56	1.96	1.77	0.79	0.79	0.79	0.59	1.57	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	111.71	2.29	1.02	0.76	0.25	0.51	1.52	0.51	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	161.83	1.69	3.38	0.00	1.13	0.56	2.26	1.13	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	162.93	1.81	4.65	0.77	4.91	2.84	0.77	1.29	0.26	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	131.72	1.52	3.04	0.38	3.04	0.00	1.52	1.90	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	272.68	1.75	5.26	0.58	2.63	1.75	2.63	1.46	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	311.51	3.88	4.74	2.59	6.25	2.15	1.72	2.15	0.65	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	277.35	3.34	4.59	2.50	3.75	2.92	0.83	2.50	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	165.28	1.18	2.37	0.71	1.18	0.47	1.66	0.95	0.00	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	214.24	1.29	1.61	0.80	1.61	1.45	0.96	1.77	0.16	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	152.17	2.02	4.04	0.67	0.00	0.67	0.67	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	117.99	2.03	0.78	0.47	0.47	1.10	0.78	1.25	0.63	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	115.45	0.49	0.98	1.47	1.47	0.49	0.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	61.09	0.87	0.00	0.00	1.75	1.75	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	198.74	2.86	7.25	1.53	4.58	0.95	1.72	2.48	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	172.68	2.18	6.54	1.74	2.62	0.44	0.87	1.74	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	169.92	1.00	1.00	0.00	3.50	1.50	2.50	1.00	0.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	369.62	2.07	5.09	0.94	6.41	3.20	1.70	3.39	0.19	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	332.40	3.64	9.09	1.36	9.55	4.55	2.73	3.64	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	329.52	1.57	3.13	0.94	5.01	2.19	2.51	0.94	0.94	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	177.35	0.65	1.63	0.82	3.92	1.31	1.63	1.14	0.33	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	174.48	1.16	1.74	1.45	1.74	1.74	1.16	0.58	0.00	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	217.32	0.60	2.09	0.30	1.49	1.20	0.90	2.39	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	97.36	1.48	2.22	0.18	1.29	0.55	1.48	0.74	0.18	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	124.10	1.43	2.57	0.86	1.14	0.86	1.43	0.29	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	104.53	0.82	1.63	0.00	1.63	0.41	1.22	0.00	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	144.00	2.46	3.52	1.41	2.46	0.35	2.11	1.76	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	131.76	2.22	4.43	0.63	3.17	1.27	0.32	2.22	0.32	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	142.23	1.51	4.54	0.30	3.93	0.30	0.91	0.91	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	192.37	0.52	5.17	0.00	2.07	1.03	3.62	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	202.57	3.98	3.32	0.66	0.66	0.00	0.66	1.99	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	147.51	2.05	2.31	0.51	0.77	1.80	1.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	132.68	1.53	2.81	0.26	0.77	1.28	0.51	0.51	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	184.01	2.27	5.30	0.00	2.27	0.00	1.51	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	122.32	1.68	1.34	1.01	1.01	0.67	1.68	0.67	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	100.47	0.72	1.93	0.72	0.97	1.21	0.97	0.24	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	76.65	1.34	2.67	0.89	2.23	0.45	1.34	0.45	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	115.61	2.44	2.93	0.49	1.46	0.98	1.46	0.49	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	155.56	3.67	4.28	0.00	4.28	0.61	0.92	0.61	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	29.28	0.00	0.00	0.00	9.76	3.25	0.00	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	105.57	0.33	2.32	0.99	2.65	2.32	1.65	1.32	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	276.93	2.19	4.93	0.55	4.93	2.74	2.74	1.64	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	238.12	1.45	2.53	0.00	2.90	0.36	1.45	2.53	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	222.78	0.00	3.56	0.71	1.78	0.71	1.78	2.14	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	150.37	0.00	1.19	0.00	0.00	0.00	2.39	4.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	253.25	0.81	1.90	0.14	3.11	1.63	0.81	1.08	0.41	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	160.83	0.27	2.42	0.27	1.62	0.54	1.08	0.81	0.00	0.27
immature langerhans cells, donor1	11904-125F5	715.06	29.78	15.50	8.72	0.00	1.94	3.15	1.70	0.48	0.00
immature langerhans cells, donor2	11905-125F6	864.22	26.93	14.26	14.26	1.58	0.00	4.75	2.38	0.79	0.00
insula, adult, pool1	10039-101F3	360.65	9.84	8.90	3.69	0.38	0.85	0.28	0.57	0.09	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	71.21	4.55	6.83	0.65	0.33	0.00	0.00	0.33	0.00	0.33
kidney, adult, pool1	10017-101C8	130.17	4.51	8.11	1.40	0.60	1.10	0.20	0.60	0.10	0.10
kidney, fetal, pool1	10045-101F9	321.56	6.72	8.98	3.96	0.21	1.13	0.50	0.71	0.21	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	76.83	5.96	7.81	1.56	0.43	0.14	0.28	0.14	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	81.70	2.90	2.35	1.24	0.00	0.55	0.55	0.28	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	173.77	7.89	3.85	1.65	0.18	0.18	0.37	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	120.41	3.27	7.08	1.63	0.00	1.09	0.00	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	111.75	2.02	2.53	1.01	0.51	0.51	0.00	1.52	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	136.53	7.11	8.76	2.46	0.00	0.27	0.82	0.55	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	62.87	6.11	5.39	3.59	0.36	1.44	0.00	0.72	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	22.28	2.17	0.54	1.09	0.00	0.54	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	42.74	4.61	2.91	2.43	0.00	0.24	0.24	0.49	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	107.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	134.88	8.36	13.59	3.14	4.18	0.00	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	436.34	27.74	19.13	13.81	0.94	1.53	0.94	1.18	0.47	0.59
liposarcoma cell line:KMLS-1	10782-110G8	34.05	3.12	3.91	1.72	0.16	0.31	0.31	0.31	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	94.55	4.63	7.07	2.07	0.12	0.24	0.85	0.24	0.12	0.00
liver, adult, pool1	10018-101C9	182.48	3.57	4.54	0.81	1.13	0.49	0.32	0.65	0.00	0.00
liver, fetal, pool1	10086-102B5	236.12	5.64	0.94	2.82	0.94	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	213.63	7.00	6.42	2.19	0.58	0.44	1.02	0.58	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	194.70	2.95	2.77	2.03	0.00	1.29	0.74	1.48	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	180.85	5.08	8.46	3.39	0.85	1.69	1.13	1.41	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	74.87	1.68	5.05	0.84	0.42	0.84	1.26	0.84	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	65.05	2.77	2.91	1.38	0.28	0.42	0.14	0.14	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	92.38	6.20	5.52	5.52	0.00	0.69	0.00	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	30.58	5.01	8.70	2.37	0.26	0.40	0.66	0.26	0.26	0.00
lung, adult, pool1	10019-101D1	503.58	9.92	12.52	2.01	5.08	1.06	2.72	1.42	0.12	0.71
lung, fetal, donor1	10068-101I5	525.15	11.99	11.42	2.85	1.43	2.28	2.28	0.86	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	240.11	11.00	6.42	5.04	5.04	1.83	1.37	0.92	0.46	0.92
lymph node, adult, donor1	10077-102A5	99.88	2.84	8.05	0.95	0.47	0.47	0.00	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	222.68	5.26	2.41	0.66	1.53	1.32	1.53	0.44	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	71.69	0.91	1.36	0.15	0.00	0.30	0.15	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	58.62	0.85	0.85	0.00	0.00	0.00	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	2635.52	18.20	9.32	5.33	3.11	3.55	4.00	2.66	0.89	0.00
mature adipocyte, donor2	12232-129F9	2003.48	15.98	5.60	3.11	1.87	2.70	6.02	2.70	0.42	0.83
mature adipocyte, donor3	12233-129G1	1576.23	9.01	9.72	3.56	0.95	4.50	3.56	2.13	0.71	0.47
mature adipocyte, donor4	12234-129G2	1585.88	14.48	16.58	5.79	1.58	3.16	5.00	2.11	0.53	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	161.06	3.57	6.19	1.19	1.67	0.24	0.48	0.71	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	150.03	3.38	5.64	2.26	1.13	1.13	0.00	0.00	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	219.22	6.25	4.05	2.02	0.18	0.74	0.74	1.66	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	176.63	7.94	12.07	2.22	0.64	0.32	1.59	0.95	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	52.88	2.99	5.12	0.85	0.85	0.00	0.00	0.00	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	210.60	7.76	9.96	2.03	0.00	1.69	0.51	1.18	0.51	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	207.13	4.46	3.61	1.27	0.64	0.64	0.42	1.27	0.21	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	125.21	17.34	7.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	114.83	14.35	14.35	0.00	0.00	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	152.19	5.38	6.10	4.31	0.72	0.72	0.00	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	178.47	5.19	4.54	1.95	0.65	0.65	0.65	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	175.39	5.26	1.55	1.24	0.46	0.93	0.31	0.93	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	317.61	5.63	4.41	2.29	0.57	0.65	0.24	0.33	0.16	0.08
medulla oblongata, newborn, donor10223	10361-105F1	127.76	3.12	2.08	1.39	0.35	0.00	1.04	0.69	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	290.49	7.53	3.99	0.89	0.44	1.55	1.11	0.89	0.22	0.44
medulloblastoma cell line:ONS-76	10759-110E3	69.45	2.08	3.06	2.08	0.12	0.24	0.24	0.00	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	57.64	2.16	2.30	0.72	0.29	0.43	0.29	0.43	0.00	0.00
melanoma cell line:G-361	10465-106H6	96.91	4.61	8.69	2.17	3.26	0.54	1.36	0.81	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	41.79	2.89	5.07	1.27	0.00	0.00	0.18	0.36	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	153.32	5.29	14.10	1.76	0.88	1.76	1.76	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	306.14	3.37	4.15	1.56	0.26	2.07	2.07	0.52	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	61.53	3.99	5.22	2.30	0.15	0.77	0.15	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	85.44	4.00	4.18	1.64	0.00	0.00	0.18	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	58.39	5.80	4.97	2.90	0.41	0.41	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	117.30	7.45	3.93	4.07	0.14	0.56	0.14	0.14	0.28	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	89.16	7.13	5.01	1.73	0.39	0.19	0.58	0.19	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	65.24	9.02	4.86	2.78	2.08	1.39	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	129.76	4.81	6.69	2.92	0.34	0.51	0.51	1.03	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	114.79	6.67	4.72	3.22	0.69	0.69	0.12	0.58	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	81.57	2.79	3.85	2.12	0.00	0.27	0.27	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	51.72	2.43	2.16	1.49	0.14	0.00	0.14	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	65.16	2.28	3.27	1.56	0.14	0.14	0.43	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	88.93	6.59	4.61	3.29	0.00	0.66	0.66	0.66	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	76.66	4.15	3.74	2.08	0.28	0.14	0.00	0.28	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	46.78	2.09	4.54	2.09	0.35	0.70	0.35	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	53.90	2.25	3.27	1.02	0.00	0.20	0.41	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	84.11	5.03	6.83	1.44	0.36	0.36	0.36	0.72	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	116.07	4.76	4.03	1.76	0.52	0.52	0.72	0.00	0.00	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	33.97	0.46	2.28	1.82	0.23	0.46	0.00	0.68	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	29.79	1.68	0.84	0.42	0.00	0.42	0.00	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	101.47	2.84	3.74	1.94	0.60	0.60	0.30	0.75	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	113.26	5.25	4.55	2.36	0.09	0.35	0.53	0.26	0.09	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	132.17	11.78	7.73	1.47	0.37	0.37	0.37	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	59.81	4.86	3.15	2.00	0.57	0.86	0.86	0.86	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	66.52	2.11	2.95	0.42	0.00	0.42	0.00	0.00	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	56.17	5.02	5.48	2.74	0.00	0.46	0.46	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	48.60	5.12	2.30	1.02	0.00	0.26	0.26	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	52.87	4.97	3.66	2.88	0.26	0.26	0.00	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	52.68	4.93	4.93	1.23	0.31	1.23	0.92	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	45.42	4.71	4.94	1.18	0.94	0.24	0.47	0.24	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	50.77	3.38	3.72	4.40	0.34	1.02	0.00	0.68	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	50.30	7.47	6.68	3.54	0.39	0.39	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	38.92	2.78	5.56	1.39	0.46	0.00	0.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	58.55	6.92	3.46	3.46	0.29	0.00	0.29	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	48.19	5.80	5.13	2.23	0.22	0.22	0.45	0.00	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	48.79	5.05	4.81	2.88	0.24	0.48	0.00	0.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	41.07	3.67	5.13	2.20	0.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	51.36	4.03	4.03	1.68	0.34	0.34	0.67	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	40.94	6.96	3.28	3.68	0.41	0.00	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	44.67	1.72	4.30	1.29	0.43	0.86	0.43	0.43	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	5.47	5.47	0.00	0.00	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	51.65	10.33	0.00	0.00	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	49.37	3.90	4.55	0.65	0.00	0.65	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	55.29	1.45	7.27	0.00	0.00	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	66.10	5.33	8.53	1.60	0.00	1.07	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	57.24	2.45	2.45	0.82	0.00	0.82	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	51.31	3.11	3.50	1.55	0.00	0.78	0.78	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	54.57	6.30	0.00	0.00	0.00	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	53.65	1.99	3.97	1.99	0.00	0.99	0.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	45.07	1.19	5.34	3.56	0.00	0.00	1.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	43.86	0.00	8.53	2.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	39.90	4.43	1.90	1.27	0.63	0.63	0.63	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	43.80	1.72	2.76	0.69	0.34	0.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	0.00	4.30	0.00	0.00	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	0.00	7.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	0.00	3.44	0.00	0.00	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	34.63	2.44	3.26	2.04	0.41	0.41	0.41	0.00	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	33.37	3.18	4.77	1.59	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	39.50	1.77	4.13	0.00	0.00	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	30.24	1.25	3.43	0.00	0.31	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	42.77	0.00	0.00	1.34	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	1.18	1.18	0.00	0.00	1.18	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	2.57	2.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	29.60	1.38	8.26	0.69	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	22.76	0.49	2.97	2.47	0.00	0.00	0.00	0.49	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	21.31	2.24	0.00	1.12	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	29.26	1.27	1.91	1.91	0.00	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	49.16	3.22	2.01	1.61	0.00	0.40	0.40	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	67.60	2.18	8.72	2.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	70.96	2.53	1.27	2.53	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	104.38	3.03	2.43	0.61	0.00	0.00	0.00	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	131.05	0.00	9.04	0.00	0.00	0.00	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	96.37	0.82	8.24	4.12	1.65	1.65	0.00	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	50.80	5.36	3.17	0.60	0.00	0.20	0.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	36.34	3.24	5.52	0.32	0.65	0.00	0.00	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	46.86	7.13	8.15	2.04	0.00	1.02	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	211.22	7.74	5.42	1.55	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	130.41	7.32	8.50	3.31	0.24	0.24	0.94	0.71	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	91.28	2.32	3.01	1.85	0.00	0.70	0.93	0.46	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	123.93	17.09	12.82	4.27	0.00	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	117.85	4.93	3.29	1.75	0.51	0.82	0.31	0.21	0.21	0.00
mesothelioma cell line:Mero-25	10850-111F4	85.56	2.04	3.18	1.82	0.23	1.13	0.91	0.45	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	44.49	0.73	4.16	1.22	0.00	0.00	0.24	0.24	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	53.59	5.31	3.99	0.89	0.00	0.44	0.44	0.89	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	78.32	6.31	4.20	2.89	0.00	0.00	0.79	0.79	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	101.96	3.57	3.92	0.68	1.02	0.51	0.17	0.17	0.00	0.51
mesothelioma cell line:Mero-84	10855-111F9	96.05	3.29	3.54	1.01	0.00	0.76	0.76	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	93.79	5.59	5.18	1.24	0.00	0.41	0.83	0.83	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	36.94	2.82	2.48	0.66	0.00	0.66	0.50	0.00	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	36.56	4.89	1.63	1.45	0.00	0.18	0.36	0.18	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	49.20	5.81	4.95	1.37	0.17	1.02	0.34	0.17	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	45.29	3.31	6.11	2.29	0.00	0.25	0.25	0.25	0.00	0.25
mesothelioma cell line:No36	10857-111G2	61.33	2.94	2.94	0.33	0.00	1.30	0.33	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	50.13	6.50	4.61	2.44	0.00	0.54	0.27	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	83.49	7.87	11.90	1.92	0.19	0.96	0.96	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	143.12	12.58	14.29	4.52	0.12	0.61	0.85	0.61	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	118.64	7.18	9.15	1.62	0.00	0.00	0.18	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	74.44	2.94	5.88	1.63	0.33	0.00	1.96	0.98	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	47.05	2.33	4.66	1.06	0.00	0.42	0.21	0.21	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	57.59	5.53	6.22	2.99	0.00	0.00	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	630.44	43.96	10.28	18.27	3.43	4.95	3.81	1.90	0.57	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	173.52	3.14	4.99	1.85	0.00	1.29	0.92	0.92	0.18	0.00
myeloma cell line:PCM6	10474-106I6	78.08	5.14	10.28	4.74	0.00	0.40	0.79	0.40	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	127.84	4.57	3.04	2.54	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	132.59	10.00	10.79	3.92	0.59	0.20	0.98	0.78	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	124.46	1.56	1.78	0.67	0.45	0.22	0.33	0.22	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	116.19	1.25	2.65	1.03	0.29	0.66	0.74	0.22	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	125.30	4.42	2.76	2.21	0.00	1.10	0.55	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	175.31	1.38	3.45	0.23	0.23	0.69	0.69	0.23	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	269.03	5.80	5.05	1.12	0.19	1.50	1.31	0.75	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	102.70	2.74	1.69	1.05	0.84	1.05	0.42	0.42	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	176.85	2.42	4.85	0.19	0.56	0.93	1.12	0.19	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	156.09	6.88	2.14	2.14	0.24	0.24	0.47	0.47	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	238.52	8.24	4.12	1.43	3.64	1.43	2.22	1.11	0.32	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	201.66	1.01	3.82	0.60	0.20	1.41	1.41	0.40	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	308.98	1.27	7.63	0.64	0.64	0.00	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	114.72	7.45	4.52	2.66	0.27	0.27	0.27	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14354.19	14.87	29.75	14.87	0.00	0.00	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	730.44	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	1013.36	18.94	18.94	0.00	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	93.35	3.55	16.91	1.18	0.00	1.01	0.51	0.34	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	421.07	1.60	5.60	3.20	0.00	0.80	2.40	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	265.14	10.26	8.02	3.85	1.60	1.60	1.28	1.60	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	65.69	4.47	3.15	2.10	0.00	1.31	0.26	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	310.56	8.25	6.00	2.62	0.66	0.66	0.28	0.37	0.09	0.00
occipital cortex - adult, donor10196	10172-103C1	138.05	4.12	16.48	2.06	0.00	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	228.65	4.56	2.42	1.61	0.27	0.81	0.54	1.34	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	149.94	4.37	6.91	2.18	0.00	0.00	0.00	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	185.25	6.82	7.61	2.62	4.99	1.31	3.94	2.10	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	148.90	1.72	3.43	0.86	0.43	0.00	0.00	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	368.66	8.12	7.25	1.97	0.63	1.26	0.32	0.63	0.39	0.00
olfactory region, adult	10195-103E6	174.05	6.11	5.92	1.72	0.38	0.76	0.76	0.57	0.19	0.38
optic nerve, donor1	10277-104E7	362.19	6.00	8.00	4.00	8.00	0.00	0.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	136.23	4.44	5.24	1.48	1.25	1.03	0.46	0.34	0.00	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	60.04	0.55	1.10	0.14	0.14	0.27	0.00	0.00	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	55.88	4.74	3.89	2.71	0.00	0.34	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	144.62	4.85	5.08	2.08	0.58	1.04	0.69	0.23	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	131.11	5.59	10.29	2.35	1.18	0.88	0.00	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	93.43	0.93	6.54	2.80	0.00	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	217.36	8.91	6.36	3.82	1.27	0.85	1.27	0.64	0.00	0.21
ovary, adult, pool1	10020-101D2	540.01	20.44	13.45	7.42	2.88	1.40	1.31	1.48	0.17	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	95.33	4.22	3.30	4.03	0.37	0.37	0.92	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	135.45	1.88	5.64	3.76	0.00	0.94	0.94	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	125.79	9.22	10.34	2.80	0.84	0.56	0.56	0.28	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	64.39	2.73	2.21	2.04	0.00	0.34	0.68	0.34	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	121.70	6.79	4.47	1.49	0.33	0.66	0.66	0.17	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	339.64	7.78	8.24	2.93	0.55	1.28	0.37	0.64	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	113.04	2.20	2.94	1.47	0.00	0.00	0.00	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	167.41	2.82	2.82	1.88	0.00	0.94	0.94	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	210.93	4.28	3.71	0.57	0.00	0.57	1.14	1.14	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	335.47	8.28	6.87	3.26	0.44	1.06	0.53	0.70	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	183.30	0.97	0.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	115.15	6.73	8.22	3.74	0.37	0.37	1.12	0.00	0.37	0.00
parotid gland, adult	10199-103F1	109.77	3.70	5.55	1.23	0.00	0.62	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	197.12	10.74	4.30	3.22	0.54	1.07	1.07	1.07	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	104.68	4.46	4.46	0.37	0.37	0.93	0.93	0.56	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	98.64	4.37	1.60	1.17	0.44	0.00	0.44	0.29	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	100.62	5.16	2.58	0.65	1.29	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	151.01	0.00	4.74	1.18	0.00	0.00	0.59	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	97.20	0.63	5.64	0.63	0.00	0.00	1.25	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	220.57	6.07	6.07	2.02	0.00	1.01	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	327.30	3.13	9.38	2.08	0.00	1.04	0.00	1.04	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	199.19	8.51	14.47	4.26	0.00	0.00	0.00	1.70	0.85	0.00
placenta, adult, pool1	10021-101D3	564.39	11.40	10.00	3.55	1.61	1.51	1.08	1.08	0.22	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	97.86	3.58	3.44	1.72	0.13	0.66	0.26	0.40	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	104.59	7.00	5.45	2.49	0.16	0.47	0.16	0.47	0.16	0.16
pons, adult, pool1	10033-101E6	233.50	2.32	2.75	1.03	0.60	0.60	0.60	0.77	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	369.89	8.37	8.11	3.31	1.22	1.31	0.78	1.13	0.00	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	3624.39	31.37	56.47	8.37	2.09	0.00	2.09	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	468.18	0.00	0.00	0.00	0.00	5.51	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	457.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	64.38	7.43	5.83	3.50	0.29	0.58	0.44	0.15	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	79.32	4.90	3.09	0.91	0.18	0.73	0.36	0.00	0.00	0.00
prostate, adult, pool1	10022-101D4	242.06	12.79	9.70	2.27	1.63	1.09	0.45	1.18	0.09	0.27
putamen, adult, donor10196	10176-103C5	198.29	4.49	4.01	0.94	0.24	0.94	0.94	0.47	0.00	0.24
putamen, adult, donor10252	10152-102I8	323.52	0.00	0.00	0.00	0.00	0.00	3.92	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	64.48	6.56	7.65	0.00	0.00	0.00	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	156.56	2.90	4.11	0.97	0.48	1.21	0.72	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	30.74	1.50	3.75	0.00	0.00	0.75	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	189.11	4.65	2.33	0.58	1.45	0.29	0.58	0.00	0.00	0.29
rectum, fetal, donor1	10067-101I4	357.48	23.65	6.95	1.39	0.00	1.39	2.78	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	44.52	3.18	7.42	2.33	0.00	0.42	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	100.65	4.97	11.60	5.38	0.00	2.49	1.24	0.83	0.83	0.00
retina, adult, pool1	10030-101E3	344.42	7.26	7.95	1.79	1.19	1.79	0.50	0.70	0.20	0.10
retinoblastoma cell line:Y79	10475-106I7	134.32	1.82	2.86	0.78	0.00	0.52	1.56	0.78	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	62.33	2.09	4.92	1.35	0.12	0.00	0.25	0.00	0.12	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	344.47	1.41	2.25	1.12	0.28	0.84	0.56	0.28	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	159.91	6.82	9.85	0.76	0.00	0.00	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	25.09	2.10	3.08	1.29	0.32	0.16	0.32	0.00	0.00	0.00
salivary acinar cells, donor2	11772-123I8	39.52	3.03	3.03	0.96	0.55	0.28	0.00	0.28	0.14	0.14
salivary acinar cells, donor3	11773-123I9	115.20	7.28	7.28	2.65	0.00	0.00	0.00	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	205.90	8.58	4.58	0.00	0.00	0.57	0.57	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	71.07	4.22	5.99	2.11	0.42	0.51	0.59	0.59	0.08	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	79.70	4.82	6.58	3.06	0.35	0.47	0.59	0.24	0.00	0.00
seminal vesicle, adult	10201-103F3	232.79	18.52	6.88	8.47	1.06	1.59	4.76	4.23	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	243.90	16.03	7.04	7.77	1.21	1.46	0.49	0.97	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	301.46	4.78	11.32	2.77	0.75	3.02	2.01	0.75	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	47.17	1.00	3.01	1.00	0.00	2.01	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	393.96	16.39	7.52	4.03	0.94	2.82	2.01	1.07	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	76.49	2.10	1.33	0.77	0.11	0.22	0.44	0.22	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	81.93	10.19	5.94	4.13	0.13	0.52	1.03	0.39	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	57.46	2.84	2.13	0.00	0.00	0.00	2.84	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	187.58	2.76	5.28	1.08	0.96	0.72	0.60	0.48	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	250.25	5.03	15.08	6.03	0.00	1.01	2.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	115.35	6.79	6.79	6.79	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	249.33	6.94	8.84	1.26	0.63	3.16	3.79	1.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	187.44	2.33	5.34	1.00	0.67	0.00	0.00	0.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	400.63	3.15	3.47	0.63	1.26	5.04	1.26	2.21	0.63	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	324.78	6.75	10.41	2.31	0.39	3.08	2.70	1.54	0.58	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	64.78	0.66	0.82	0.16	0.49	0.16	0.33	0.16	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	312.69	8.36	5.47	1.45	0.80	1.77	1.29	1.29	0.32	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	131.62	3.49	3.27	0.44	1.09	0.22	0.22	0.22	0.00	0.00
small intestine, adult, pool1	10024-101D6	547.88	28.43	9.67	6.69	10.75	3.34	1.79	2.63	0.60	0.48
small intestine, fetal, donor1	10064-101I1	131.69	8.11	7.13	1.47	0.00	0.49	0.00	0.49	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	67.70	9.75	8.72	3.08	0.00	0.51	0.00	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	180.66	15.25	7.50	4.91	0.52	1.29	0.26	0.00	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	109.89	11.52	9.11	6.43	0.27	0.00	0.27	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	218.85	4.82	4.13	3.21	1.61	0.69	0.23	0.69	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	171.51	0.79	1.97	1.18	0.39	0.00	0.39	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	73.33	0.00	2.77	1.38	0.00	0.69	0.00	0.69	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	353.70	4.27	4.27	3.05	0.00	1.83	1.22	0.61	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	99.65	1.84	1.84	0.46	0.46	0.00	0.46	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	86.48	7.02	6.12	4.03	0.15	0.15	0.60	0.30	0.15	0.00
spleen, adult, pool1	10025-101D7	185.25	3.41	8.48	1.87	1.32	0.88	0.55	0.99	0.00	0.11
spleen, fetal, pool1	10044-101F8	254.26	5.48	7.39	1.83	1.19	0.72	0.32	0.48	0.08	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	72.56	3.93	3.93	1.66	0.21	0.21	0.62	0.21	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	116.96	1.14	1.90	1.14	0.57	0.38	0.38	0.00	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	123.01	4.54	2.10	0.70	0.00	0.70	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	64.89	1.17	2.74	0.39	0.00	0.00	0.39	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	228.16	1.24	1.91	0.34	0.45	0.90	1.01	0.79	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	151.23	4.66	5.51	1.27	0.42	1.27	1.27	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	65.58	2.54	6.35	0.85	0.00	0.00	0.00	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	459.23	10.68	9.61	5.34	0.00	0.00	2.14	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	142.42	5.13	5.13	1.14	0.57	1.71	0.57	0.00	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	488.47	54.27	0.00	0.00	0.00	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	182.99	3.12	1.87	1.04	0.21	1.45	1.25	0.62	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	117.42	3.62	8.79	0.00	0.00	1.03	1.55	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	103.16	2.83	2.12	0.71	0.00	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	161.86	0.23	1.83	0.46	0.00	0.00	0.69	0.23	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	431.48	8.99	10.17	4.58	1.27	1.27	1.10	1.78	0.00	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	173.08	0.71	1.42	0.71	0.00	0.00	2.14	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	112.08	0.88	2.20	0.00	0.00	0.88	1.32	0.88	0.00	0.44
tenocyte, donor1	11763-123H8	79.25	8.38	10.47	2.09	0.35	1.40	1.05	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	67.91	4.20	9.92	0.76	0.00	0.38	0.76	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	89.70	10.01	2.97	3.34	0.00	0.37	0.37	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	67.81	1.19	2.38	1.70	0.34	0.00	0.00	0.17	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	190.84	2.62	3.85	1.39	0.92	1.39	0.92	0.62	0.00	0.77
teratocarcinoma cell line:PA-1	10807-111A6	122.59	1.24	1.39	0.15	0.00	0.62	0.46	0.46	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	112.48	1.65	2.16	0.63	0.76	0.76	0.51	0.25	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	85.47	0.76	1.89	0.76	0.38	1.51	1.13	0.38	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	219.65	7.09	6.00	2.29	1.42	0.98	0.87	0.65	0.00	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	80.77	1.63	0.98	0.00	0.65	0.33	0.00	0.65	0.00	0.00
testis, adult, pool1	10026-101D8	425.62	8.91	17.61	3.65	3.33	0.97	0.64	1.93	0.32	0.32
testis, adult, pool2	10096-102C6	190.81	5.86	7.67	0.45	0.00	2.71	0.90	0.90	0.00	0.00
thalamus - adult, donor10196	10168-103B6	221.90	1.10	1.10	3.31	0.00	1.10	2.21	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	197.07	4.38	3.91	2.50	0.63	0.94	0.94	0.47	0.47	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	112.39	6.16	6.16	0.00	0.00	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	152.34	5.11	3.62	2.14	0.16	0.66	0.66	1.15	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	51.20	2.88	1.15	1.15	1.15	0.58	0.58	0.58	0.00	0.00
throat, adult	10209-103G2	156.54	7.74	5.24	2.25	6.24	0.75	1.75	0.50	0.25	0.00
throat, fetal, donor1	10061-101H7	221.52	3.35	7.01	0.61	0.91	0.30	0.00	0.91	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	32.00	0.20	0.40	0.20	0.00	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	264.64	3.38	5.47	0.80	2.68	0.40	0.40	0.50	0.10	0.00
thymus, fetal, pool1	10043-101F7	290.41	4.36	6.34	1.14	1.25	0.62	0.83	0.62	0.10	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	89.62	9.31	7.98	4.12	0.53	0.40	0.53	0.40	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	158.55	12.71	4.89	3.35	0.56	0.14	0.84	0.42	0.00	0.14
thyroid, adult, pool1	10028-101E1	186.44	4.39	10.45	2.15	1.49	0.84	0.19	0.37	0.37	0.09
thyroid, fetal, donor1	10060-101H6	362.54	12.66	6.86	5.27	0.79	1.85	0.26	0.53	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	194.02	9.24	3.08	3.08	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	216.53	6.51	4.65	3.95	0.23	2.33	1.40	2.09	0.00	0.23
tongue, fetal, donor1	10059-101H5	308.18	6.70	5.52	1.97	1.18	1.97	1.18	1.58	0.00	0.00
tonsil, adult, pool1	10047-101G2	217.08	5.91	5.71	0.90	0.60	0.40	1.20	0.80	0.00	0.10
trachea, adult, pool1	10029-101E2	200.65	5.48	6.54	2.29	1.06	1.55	0.25	0.65	0.00	0.16
trachea, fetal, donor1	10058-101H4	216.58	5.39	9.62	3.85	0.77	0.77	1.15	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	63.06	5.31	4.61	1.06	0.35	0.00	0.35	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	78.22	1.52	2.13	0.91	0.10	0.41	0.30	0.10	0.00	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	226.88	11.28	10.65	5.95	2.51	1.72	1.25	1.72	0.31	0.31
tridermal teratoma cell line:HGRT	10694-109G1	211.18	1.90	13.32	1.90	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	63.83	7.11	6.35	2.03	0.34	0.25	0.42	0.00	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	229.52	4.17	4.17	4.17	0.00	2.09	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	365.66	12.97	7.51	2.56	0.34	1.37	0.34	0.68	0.17	0.00
uterus, fetal, donor1	10055-101H1	184.29	7.17	7.68	2.56	0.00	0.51	1.02	0.00	0.00	0.00
vagina, adult	10204-103F6	191.92	7.75	8.40	1.94	1.94	1.29	1.29	1.94	0.00	0.00
vein, adult	10191-103E2	199.25	7.89	5.04	1.75	1.10	1.75	0.44	0.66	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	64.89	3.47	4.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Property "Nearest transcripts" (as page type) with input value "LF372674:67 MA608251:67 X51346:73 ENST00000252818.5:-146 NM_001286968.2:-146 NM_005354.6:-146 LF384383:-146 MA619960:-146 AK223630:-146 X56681:-182 BC169273:188 LF372675:289 MA608252:289 DQ594578:360 LF208134:-424 MA443711:-424 LF213747:-424 MA449324:-424 BC169274:479 LF372676:494 MA608253:494 ENST00000600972.1:498" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.